Form 1-A Issuer Information UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-A
REGULATION A OFFERING STATEMENT
UNDER THE SECURITIES ACT OF 1933
OMB APPROVAL

FORM 1-A

OMB Number: 3235-0286


Estimated average burden hours per response: 608.0

1-A: Filer Information

Issuer CIK
0001393901
Issuer CCC
XXXXXXXX
DOS File Number
Offering File Number
024-11028
Is this a LIVE or TEST Filing? LIVE TEST
Would you like a Return Copy?
Notify via Filing Website only?
Since Last Filing?

Submission Contact Information

Name
Phone
E-Mail Address

1-A: Item 1. Issuer Information

Issuer Infomation

Exact name of issuer as specified in the issuer's charter
MEDX HOLDINGS INC.
Jurisdiction of Incorporation / Organization
WYOMING
Year of Incorporation
2006
CIK
0001393901
Primary Standard Industrial Classification Code
GENERAL BLDG CONTRACTORS - NONRESIDENTIAL BLDGS
I.R.S. Employer Identification Number
20-5973352
Total number of full-time employees
1
Total number of part-time employees
0

Contact Infomation

Address of Principal Executive Offices

Address 1
1621 Central Avenue
Address 2
City
Cheyenne
State/Country
WYOMING
Mailing Zip/ Postal Code
82001
Phone
612-615-9334

Provide the following information for the person the Securities and Exchange Commission's staff should call in connection with any pre-qualification review of the offering statement.

Name
Jonathan Leinwand
Address 1
Address 2
City
State/Country
Mailing Zip/ Postal Code
Phone

Provide up to two e-mail addresses to which the Securities and Exchange Commission's staff may send any comment letters relating to the offering statement. After qualification of the offering statement, such e-mail addresses are not required to remain active.

Financial Statements

Industry Group (select one) Banking Insurance Other

Use the financial statements for the most recent period contained in this offering statement to provide the following information about the issuer. The following table does not include all of the line items from the financial statements. Long Term Debt would include notes payable, bonds, mortgages, and similar obligations. To determine "Total Revenues" for all companies selecting "Other" for their industry group, refer to Article 5-03(b)(1) of Regulation S-X. For companies selecting "Insurance", refer to Article 7-04 of Regulation S-X for calculation of "Total Revenues" and paragraphs 5 and 7 of Article 7-04 for "Costs and Expenses Applicable to Revenues".

Balance Sheet Information

Cash and Cash Equivalents
$ 567001.00
Investment Securities
$ 0.00
Total Investments
$
Accounts and Notes Receivable
$ 648449.00
Loans
$
Property, Plant and Equipment (PP&E):
$ 400310.00
Property and Equipment
$
Total Assets
$ 2657310.00
Accounts Payable and Accrued Liabilities
$ 3219.00
Policy Liabilities and Accruals
$
Deposits
$
Long Term Debt
$ 0.00
Total Liabilities
$ 218348.00
Total Stockholders' Equity
$ 2438962.00
Total Liabilities and Equity
$ 2657310.00

Statement of Comprehensive Income Information

Total Revenues
$ 676613.00
Total Interest Income
$
Costs and Expenses Applicable to Revenues
$ 280651.00
Total Interest Expenses
$
Depreciation and Amortization
$ 6099.00
Net Income
$ 301065.00
Earnings Per Share - Basic
$ 0.00
Earnings Per Share - Diluted
$ 0.00
Name of Auditor (if any)

Outstanding Securities

Common Equity

Name of Class (if any) Common Equity
Common Equity
Common Equity Units Outstanding
146616216
Common Equity CUSIP (if any):
58403T107
Common Equity Units Name of Trading Center or Quotation Medium (if any)
OTC Markets

Preferred Equity

Preferred Equity Name of Class (if any)
Preferred Equity
Preferred Equity Units Outstanding
4400000
Preferred Equity CUSIP (if any)
N/A
Preferred Equity Name of Trading Center or Quotation Medium (if any)
N/A

Debt Securities

Debt Securities Name of Class (if any)
Debt Securities
Debt Securities Units Outstanding
0
Debt Securities CUSIP (if any):
N/A
Debt Securities Name of Trading Center or Quotation Medium (if any)
N/A

1-A: Item 2. Issuer Eligibility

Issuer Eligibility

Check this box to certify that all of the following statements are true for the issuer(s)

1-A: Item 3. Application of Rule 262

Application Rule 262

Check this box to certify that, as of the time of this filing, each person described in Rule 262 of Regulation A is either not disqualified under that rule or is disqualified but has received a waiver of such disqualification.

Check this box if "bad actor" disclosure under Rule 262(d) is provided in Part II of the offering statement.

1-A: Item 4. Summary Information Regarding the Offering and Other Current or Proposed Offerings

Summary Infomation

Check the appropriate box to indicate whether you are conducting a Tier 1 or Tier 2 offering Tier1 Tier2
Check the appropriate box to indicate whether the financial statements have been audited Unaudited Audited
Types of Securities Offered in this Offering Statement (select all that apply)
Equity (common or preferred stock)
Does the issuer intend to offer the securities on a delayed or continuous basis pursuant to Rule 251(d)(3)? Yes No
Does the issuer intend this offering to last more than one year? Yes No
Does the issuer intend to price this offering after qualification pursuant to Rule 253(b)? Yes No
Will the issuer be conducting a best efforts offering? Yes No
Has the issuer used solicitation of interest communications in connection with the proposed offering? Yes No
Does the proposed offering involve the resale of securities by affiliates of the issuer? Yes No
Number of securities offered
500000000
Number of securities of that class outstanding
146616216

The information called for by this item below may be omitted if undetermined at the time of filing or submission, except that if a price range has been included in the offering statement, the midpoint of that range must be used to respond. Please refer to Rule 251(a) for the definition of "aggregate offering price" or "aggregate sales" as used in this item. Please leave the field blank if undetermined at this time and include a zero if a particular item is not applicable to the offering.

Price per security
$ 0.0050
The portion of the aggregate offering price attributable to securities being offered on behalf of the issuer
$ 2500000.00
The portion of the aggregate offering price attributable to securities being offered on behalf of selling securityholders
$ 0.00
The portion of the aggregate offering price attributable to all the securities of the issuer sold pursuant to a qualified offering statement within the 12 months before the qualification of this offering statement
$ 0.00
The estimated portion of aggregate sales attributable to securities that may be sold pursuant to any other qualified offering statement concurrently with securities being sold under this offering statement
$ 0.00
Total (the sum of the aggregate offering price and aggregate sales in the four preceding paragraphs)
$ 2500000.00

Anticipated fees in connection with this offering and names of service providers

Underwriters - Name of Service Provider
Underwriters - Fees
$ 0.00
Sales Commissions - Name of Service Provider
Sales Commissions - Fee
$ 0.00
Finders' Fees - Name of Service Provider
Finders' Fees - Fees
$ 0.00
Audit - Name of Service Provider
Audit - Fees
$ 0.00
Legal - Name of Service Provider
Jonathan D. Leinwand, P.A.
Legal - Fees
$ 13000.00
Promoters - Name of Service Provider
Promoters - Fees
$ 0.00
Blue Sky Compliance - Name of Service Provider
Blue Sky Compliance - Fees
$ 0.00
CRD Number of any broker or dealer listed:
Estimated net proceeds to the issuer
$ 0.00
Clarification of responses (if necessary)

1-A: Item 5. Jurisdictions in Which Securities are to be Offered

Jurisdictions in Which Securities are to be Offered

Using the list below, select the jurisdictions in which the issuer intends to offer the securities

Selected States and Jurisdictions
ARIZONA
FLORIDA
NEVADA
NEW YORK
WYOMING

Using the list below, select the jurisdictions in which the securities are to be offered by underwriters, dealers or sales persons or check the appropriate box

None
Same as the jurisdictions in which the issuer intends to offer the securities
Selected States and Jurisdictions

1-A: Item 6. Unregistered Securities Issued or Sold Within One Year

Unregistered Securities Issued or Sold Within One Year

None

Unregistered Securities Issued

As to any unregistered securities issued by the issuer of any of its predecessors or affiliated issuers within one year before the filing of this Form 1-A, state:

(a)Name of such issuer
MedX Holdings, Inc.
(b)(1) Title of securities issued
Common Shares
(2) Total Amount of such securities issued
24300000
(3) Amount of such securities sold by or for the account of any person who at the time was a director, officer, promoter or principal securityholder of the issuer of such securities, or was an underwriter of any securities of such issuer.
0
(c)(1) Aggregate consideration for which the securities were issued and basis for computing the amount thereof.
$5,960. The price per share was determined pursuant to the debt conversion formula in the convertible note pursuant to which the shares were issued. The conversion formula is 50% of the lowest price per share for the 30 days prior to conversion.
(2) Aggregate consideration for which the securities listed in (b)(3) of this item (if any) were issued and the basis for computing the amount thereof (if different from the basis described in (c)(1)).

Unregistered Securities Act

(e) Indicate the section of the Securities Act or Commission rule or regulation relied upon for exemption from the registration requirements of such Act and state briefly the facts relied upon for such exemption
The shares were issued pursuant to Section 3(a)(9) of the Securities Act as they were the result of the conversion of a convertible note, and thus were the exchange of a security without any additional consideration.

As submitted to the Securities and Exchange Commission on September 16, 2019

 

Registration No. 024-11028

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 1-A

Amendment 1

 

REGULATION A OFFERING CIRCULAR

UNDER THE SECURITIES ACT OF 1933

 

MEDX HOLDINGS INC.

(Exact name of issuer as specified in its charter)

 

Wyoming

(State or other jurisdiction of incorporation or organization)

 

1621 Central Ave,

Cheyenne, WY 82001

612-532-9675

(Address, including zip code, and telephone number,

including area code, of issuer’s principal executive office)

 

Wyoming Registered Agent

1621 Central Ave

Cheyenne, WY 82001

(Name, address, including zip code, and telephone number,

including area code, of agent for service)

 

Copy to:

 

Jonathan D. Leinwand, P.A.

18851 NE 29th Ave., Suite 1011

Aventura, FL 33180

 

1540

 

20-5973352

(Primary Standard Industrial

Classification Code Number)

 

(IRS Employer

Identification Number)

 

This Offering Circular shall only be qualified upon order of the Commission, unless a subsequent amendment is filed indicating the intention to become qualified by operation of the terms of Regulation A.

 

  
 
 
 

 

PRELIMINARY OFFERING CIRCULAR _______________, 2019, SUBJECT TO COMPLETION

 

MEDX HOLDINGS INC.

 

MAXIMUM OFFERING AMOUNT: $2,500,000

 

[This is our initial public offering (the “Offering”) of securities of MEDX Holdings Inc., a Wyoming corporation (the “Company”). We are offering a maximum of 500,000,000 (Five Hundred Million) shares (the “Maximum Offering”) of our common stock, par value $.001 (the “Common Stock”) at an offering price of one-half of once cent ($.005) per share (the “Shares”) on a “best efforts” basis. This Offering will terminate on the earlier of (i) June 1, 2020, subject to extension for up to one hundred-eighty (180) days in the sole discretion of the Company; or (ii) the date on which the Maximum Offering is sold (in either case, the “Termination Date”). There is no escrow established for this Offering. We will hold closings upon the receipt of investors’ subscriptions and acceptance of such subscriptions by the Company. If, on the initial closing date, we have sold less than the Maximum Offering, then we may hold one or more additional closings for additional sales, until the earlier of: (i) the sale of the Maximum Offering or (ii) the Termination Date. There is no aggregate minimum requirement for the Offering to become effective, therefore, we reserve the right, subject to applicable securities laws, to begin applying “dollar one” of the proceeds from the Offering towards our business strategy, development expenses, offering expenses and other uses as more specifically set forth in this offering circular (“Offering Circular”). We expect to commence the sale of the Shares as of the date on which the offering statement of which this Offering Circular is a part (the Offering Statement) is qualified by the United States Securities and Exchange Commission (the “SEC”).

 

Investing in our Common Stock involves a high degree of risk. See “Risk Factors” for a discussion of certain risks that you should consider in connection with an investment in our Common Stock.

 

THE U.S. SECURITIES AND EXCHANGE COMMISSION DOES NOT PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS. THESE SECURITIES ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE COMMISSION; HOWEVER, THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE SECURITIES OFFERED ARE EXEMPT FROM REGISTRATION.

 

 

 

Price to Public

 

 

Commissions (1)

 

 

Proceeds to the Company (2)

 

Per Share

 

$ .005

 

 

$ 0

 

 

$ .005

 

Maximum Offering

 

$ 2,500,000

 

 

$ 0

 

 

$ 2,500,000

 

 

(1) The Company reserves the right to pay sales commission (or Placement Agent Fees) fee for services rendered in managing this offering at a rate, up to 10%. The Company has not engaged any broker or dealer at this time.

(2) Does not reflect payment of expenses of this offering, which are estimated to not exceed $20,000 and which include, among other things, legal fees, reproduction expenses, and actual out-of-pocket expenses incurred by The Company

 

GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN TEN PERCENT (10%) OF THE GREATER OF YOUR ANNUAL INCOME OR YOUR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(D)(2)(I)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV.

 
 
2
 
 

 

THE SECURITIES UNDERLYING THIS OFFERING STATEMENT MAY NOT BE SOLD UNTIL QUALIFIED BY THE SECURITIES AND EXCHANGE COMMISSION. THIS OFFERING CIRCULAR IS NOT AN OFFER TO SELL, NOR SOLICITING AN OFFER TO BUY, ANY SHARES OF OUR COMMON STOCK IN ANY STATE OR OTHER JURISDICTION IN WHICH SUCH SALE IS PROHIBITED.

 

INVESTMENT IN SMALL BUSINESS INVOLVES A HIGH DEGREE OF RISK, AND INVESTORS SHOULD NOT INVEST ANY FUNDS IN THIS OFFERING UNLESS THEY CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. SEE “RISK FACTORS” FOR A DISCUSSION OF CERTAIN RISKS YOU SHOULD CONSIDER BEFORE PURCHASING ANY SHARES IN THIS OFFERING.

 

AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION, WHICH WE REFER TO AS THE COMMISSION. INFORMATION CONTAINED IN THIS PRELIMINARY OFFERING CIRCULAR IS SUBJECT TO COMPLETION OR AMENDMENT. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED BEFORE THE OFFERING STATEMENT FILED WITH THE COMMISSION IS QUALIFIED. THIS PRELIMINARY OFFERING CIRCULAR SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR MAY THERE BE ANY SALES OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL BEFORE REGISTRATION OR QUALIFICATION UNDER THE LAWS OF ANY SUCH STATE. WE MAY ELECT TO SATISFY OUR OBLIGATION TO DELIVER A FINAL OFFERING CIRCULAR BY SENDING YOU A NOTICE WITHIN TWO (2) BUSINESS DAYS AFTER THE COMPLETION OF OUR SALE TO YOU THAT CONTAINS THE URL WHERE THE FINAL OFFERING CIRCULAR OR THE OFFERING STATEMENT IN WHICH SUCH FINAL OFFERING CIRCULAR WAS FILED MAY BE OBTAINED.

 

The date of this Offering Circular is _________, 2019.

 
 
3
 
 

 

TABLE OF CONTENTS

 

SUMMARY

6

 

RISK FACTORS

8

 

USE OF PROCEEDS

14

 

DILUTION

14

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

15

 

BUSINESS

22

 

MANAGEMENT

26

 

RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

26

 

DESCRIPTION OF CAPITAL

26

 

DIVIDEND POLICY

28

 

PLAN OF DISTRIBUTION

28

 

EXPERTS

29

 

SIGNATURES

30

 

PART III EXHIBITS

31

 

 

No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this Offering Circular. You must not rely on any unauthorized information or representations. This Offering Circular is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this Offering Circular is current only as of its date.

 

We are offering to sell, and seeking offers to buy, our securities only in jurisdictions where such offers and sales are permitted. You should rely only on the information contained in this Offering Circular. We have not authorized anyone to provide you with any information other than the information contained in this Offering Circular. The information contained in this Offering Circular is accurate only as of its date, regardless of the time of its delivery or of any sale or delivery of our securities. Neither the delivery of this Offering Circular nor any sale or delivery of our securities shall, under any circumstances, imply that there has been no change in our affairs since the date of this Offering Circular. This Offering Circular will be updated and made available for delivery to the extent required by the federal securities laws.

 

Unless otherwise indicated, data contained in this Offering Circular concerning the business of the Company are based on information from various public sources. Although we believe that these data are generally reliable, such information is inherently imprecise, and our estimates and expectations based on these data involve a number of assumptions and limitations. As a result, you are cautioned not to give undue weight to such data, estimates or expectations.

 

In this Offering Circular, unless the context indicates otherwise, references to “we,” the “Company,” “our,” and “us” refer to the activities of and the assets and liabilities of the business and operations of MedX Holdings Inc.

 
 
4
 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Some of the statements under “Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” "Our Business" and elsewhere in this Offering Circular constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as “anticipate”, “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” “will” and “would” or the negatives of these terms or other comparable terminology.

 

You should not place undue reliance on forward looking statements. The cautionary statements set forth in this Offering Circular, including in “Risk Factors” and elsewhere, identify important factors which you should consider in evaluating our forward-looking statements. These factors include, among other things:

 

 

· Our ability to effectively execute our business plan, including without limitation our ability to develop self-storage facilities;

 

 

 

 

· Our ability to locate suitable development sites in target markets;

 

 

 

 

· Our ability to build and maintain a team to manage our facilities;

 

 

 

 

· Our ability to compete, directly and indirectly, and succeed in the highly competitive and evolving self-storage market;

 

 

 

 

· Our ability to respond and adapt to changes in technology and customer behavior; and

 

Although the forward-looking statements in this Offering Circular are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material and adverse. We undertake no obligation, other than as may be required by law, to re-issue this Offering Circular or otherwise make public statements updating our forward-looking statements.

 
 
5
 

 

SUMMARY

 

This summary highlights selected information contained elsewhere in this Offering Circular. This summary is not complete and does not contain all the information that you should consider before deciding whether to invest in our Common Stock. You should carefully read the entire Offering Circular, including the risks associated with an investment in the company discussed in the “Risk Factors” section of this Offering Circular, before making an investment decision. Some of the statements in this Offering Circular are forward-looking statements. See the section entitled “Cautionary Statement Regarding Forward-Looking Statements.”

 

Company Information

 

The Company was incorporated on September 5, 2006 as Disaboom, Inc. under the laws of the state of Colorado. The Company was redomiciled in the State of Wyoming on December 28, 2015. Our mailing address is MedX Holdings, PO Box 194. Pequot Lakes, MN 56472. Our website address is http://www.medxholdings.co. The information contained therein or accessible thereby shall not be deemed to be incorporated into this Offering Circular.

 

Our Business

 

The Company operates through its subsidiaries MJ Builders of MN, LLC, a Minnesota limited liability corporation and DDG Properties, LLC, a Minnesota limited liability corporation. MJ Builders builds commercial and residential properties and is licensed in the state of Minnesota. DDG manages properties for rent. The Company has also created MJ Storage MN, LLC, a Minnesota limited liability corporation that will build and manage self-storage facilities.

 

MJ Builders of MN, LLC. was started in February of 2017 in Minnesota and grew out of a previous construction company owned by the Company’s CEO who has been a licensed General Contractor in the state of Minnesota for 12 years and has been a private construction contractor since May 2001.

 

DDG Properties, LLC was started in June 2011. DDG started with 9 Properties that were all single family homes. The principals of DDG used their construction experience to take distressed homes and turn them into renovated cash flow producing assets. DDG has since grown rapidly owning both commercial and residential properties. Some of the property DDG owns is land for future development.

 
 
6
 
Table of Contents

 

REGULATION A+

 

We are offering our Common Stock pursuant to recently adopted rules by the Securities and Exchange Commission mandated under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. These offering rules are often referred to as “Regulation A+.” We are relying upon “Tier 1” of Regulation A+, which allows us to offer of up to $20 million in a 12-month period

 

THE OFFERING

 

Issuer:

MedX Holdings Inc.

 

 

Shares Offered:

 

A maximum of 500,000,000 (Five Hundred Million) shares of our Common Stock (the “Maximum Offering”), at an offering price of One Half of One Cent ($.005) per share (the “Shares”).

 

Number of shares of Common Stock Outstanding before the Offering:

 

146,616,216 (One Hundred Thirty-Three Million Three Hundred Sixteen Thousand Two Hundred Sixteen) shares of Common Stock.

 

Number of shares of Common Stock to be Outstanding after the Offering:

 

646,616,216 (Six Hundred Forty-Six Million  Six Hundred Sixteen Thousand Two Hundred Sixteen) shares of Common Stock if the Maximum Offering is sold.

 

Price per Share:

 

One Half of One Cent ($.005).

 

Maximum Offering:

 

500,000,000 (Five Hundred Million) shares of our Common Stock (the “Maximum Offering”), at an offering price of One Half of One Cent ($.005) per share (the “Shares”), for total gross proceeds of Two Million Five Hundred Thousand Dollars ($2,500,000).

 

Use of Proceeds:

 

If we sell all of the Shares being offered, our net proceeds (after our estimated commissions, if any, but excluding our estimated Offering expenses) will be approximately Two Million Five Hundred Thousand Dollars ($2,500,000).. We will use these net proceeds for working capital, and such other purposes described in the “Use of Proceedssection of this Offering Circular.

 

Risk Factors:

 

Investing in our Common Stock involves a high degree of risk. See “Risk Factors.”

 
 
7
 
Table of Contents

 

RISK FACTORS

 

An investment in our Common Stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this Offering Circular, before making an investment decision. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. In that case, the trading price of our shares of common stock could decline and you may lose all or part of your investment. See “Cautionary Note Regarding Forward Looking Statements” above for a discussion of forward-looking statements and the significance of such statements in the context of this Offering Circular.

 

RISKS RELATED TO OUR COMPANY

 

Going Concern.

 

Our financial statements appearing elsewhere in this Offering Circular have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company's ability to continue as a going concern is contingent upon its ability to raise additional capital as required.]

 

Inadequacy of Capital.

 

The expected gross offering proceeds of a maximum of Two Million Five Hundred Thousand Dollars ($2,500,000) may never be realized. While we believe that such proceeds will capitalize and sustain us to allow for the continued development and implementation of our business plan, if only a fraction of this Offering is sold, or if certain assumptions contained in the business plans prove to be incorrect, we may have inadequate funds to fully develop our business. Although we believe that the proceeds from this Offering will be sufficient to help sustain our development process and business operations, there is no guarantee that we will raise all the funds needed to adequately fund our business plan.

 

Expansion to new markets will require significant employee and infrastructure investments in order to build and operate markets.

 

We plan to expand outside of our initial area of operations. This expansion plan will require significant amounts of capital and we may not be able to acquire sufficient capital through this Offering or other capital markets to enter any of these markets.

 

If we are unable to successfully expand to additional markets, our revenue growth rate and profits may be reduced or prospects thereof severely diminished.

 

Failure to expand, or delays in expansion of, our operations to new markets could hurt our ability to meet our growth objectives, which may affect our financial projections. We cannot guarantee that we will be able to achieve pour expansion goals or that operations in new markets will operate profitably. Our ability to expand successfully will depend on a number of factors, many of which are beyond our control.

 

If we expand to additional markets, we may not be able to obtain enough customers to make operations in any of these markets viable or profitable.

 

Expanding to new markets will require significant investments of effort, resources, time and capital and we may not be able to obtain enough customers in such markets to continue to fund operations in these markets.

 

Our failure to achieve brand recognition could have an adverse effect on our business.

 

We believe that establishing and maintaining brand recognition for our services will be an important aspect of our efforts to attract and expand our customer base. Promotion of our brand will depend largely on our success in providing high quality products and service. To attract and retain customers and to promote our brand in response to competitive pressures, we may find it necessary to increase substantially our financial commitment to creating and maintaining our brand, including filing trademarks and tradenames. We cannot assure that we will obtain brand recognition for the self - storage industry. Our failure to provide high quality products and service or to obtain and maintain brand recognition could have a material adverse effect on our business, results of operations, and financial condition.

 
 
8
 
Table of Contents

 

Raising additional capital by issuing additional securities may cause dilution to our current and future shareholders.

 

We may need to, or desire to, raise substantial additional capital in the future. Our future capital requirements will depend on many factors, including, among others:

 

 

·

Our degree of success in subscribing new customers to, and maintaining existing customers;

 

 

 

 

·

The cost of establishing, or acquiring, sales, and marketing;

 

 

 

 

·

The costs of financing unanticipated working capital requirements and responding to competitive pressures.

 

If we raise additional funds by issuing equity or convertible debt securities, we will reduce the percentage of ownership of the then-existing shareholders, and the holders of those newly-issued equity or convertible debt securities may have rights, preferences, or privileges senior to those possessed by our then-existing shareholders. We cannot predict the effect that future sales of our Common Stock, or other equity-related securities would have on the market price of our Common Stock at any given time.

 

We are significantly influenced by our officers, directors and entities affiliated with them.

 

Mark Miller, our sole officer and director is also the holder opf [•] shares of Series __ Preferred Stock that gives him voting control over all matters requiring approval by shareholders, including the election of directors and the approval of mergers or other business combinations transactions. Please see “Security Ownership of Management & Certain Security Holders” below for more information.

 

Our future performance is dependent on the ability to retain key personnel. The Company’s performance is substantially dependent on the performance of senior management. The loss of the services of any of its executive officers or other key employees could have a material adverse effect on the Company's business, results of operations and financial condition.

 

Unanticipated obstacles to execution of our business plan.

 

Our business plan may change significantly. Many of our potential business endeavors are capital intensive and may be subject to statutory or regulatory requirements. Our Board of Directors believes that the chosen activities and strategies are achievable in light of current economic and legal conditions with the skills, background, and knowledge of our principals and advisors. Our Board of Directors reserve the right to make significant modifications to our stated strategies depending on future events.

 

Risks of operations.

 

Our future operating results may be volatile, difficult to predict and may fluctuate significantly in the future due to a variety of factors, many of which may be outside of our control. Due to the nature of our target market, we may be unable to accurately forecast our future revenues and operating results. Furthermore, our failure to generate revenues would prevent us from achieving and maintaining profitability. There are no assurances that we can generate significant revenue or achieve profitability. We anticipate having a sizeable amount of fixed expenses, and we expect to incur losses due to the execution of our business strategy, continued development efforts and related expenses. As a result, we will need to generate significant revenues while containing costs and operating expenses if we are to achieve profitability. We cannot be certain that we will ever achieve sufficient revenue levels to achieve profitability.

 
 
9
 
Table of Contents

 

We are subject to many laws and governmental regulations and any adverse regulatory action may materially adversely affect our financial condition and business operations.

 

Our business is subject to various federal, state, and local laws and regulations affecting self storage companies, including laws governing consumer advertising, consumer services, employee relations, and wrongful termination. Changes to existing laws or the adoption of new laws applicable to self storage companies could have a material adverse effect on our business, results of operations, and financial condition. Any new legislation or regulation, or the application of laws or regulations from jurisdictions whose laws do not currently apply to our business, could have a material adverse effect of our business, results of operations, and financial condition.

 

No minimum capitalization.

 

We do not have a minimum capitalization and we may use the proceeds from this Offering immediately following our acceptance of the corresponding subscription agreements. It is possible we may only raise a minimum amount of capital, which could leave us with insufficient capital to implement our business plan, potentially resulting in greater operating losses unless we are able to raise the required capital from alternative sources. There is no assurance that alternative capital, if needed, would be available on terms acceptable to us, or at all.

 

We may incur substantial operating and net losses due to substantial expenditures.

 

We intend to increase our operating expenses and capital expenditures in order to expand our market presence. We may incur substantial operating and net losses in the foreseeable future. There can be no assurance that we will achieve or sustain profitability or positive cash flow from our operations.

 

We may not be able to manage our growth effectively.

 

Our growth is expected to place a significant strain on our managerial, operational and financial resources. There can be no assurance that our systems, procedures or controls will be adequate to support our operations or that our management will be able to achieve the rapid execution necessary to successfully offer our services and implement our business plan. Our future operating results will also depend on our ability to expand sales and marketing commensurate with the growth of our business . If we are unable to manage growth effectively, our business, results of operations and financial condition will be adversely affected.

 

Changes in U.S. economic conditions.

 

A decrease in economic activity in the United States could adversely affect demand for storage facilities and thus reduce our ability to generate revenue. A decline in economic conditions could reduce the number of customers who need to utilize our storage facilities.

 

We will face intense competition.

 

The self - storage industry is highly competitive. There are a substantial number of companies that compete directly and indirectly with us, which have significantly greater financial resources, greater name recognition, higher revenues, and greater economies of scale than those of MJ Storage MN, LLC. We cannot assure that we will have the financial resources necessary to compete with our larger better financed competitors. It is possible that increased competition could result in interest reductions and reduced operating margins which could materially and adversely affect our business, operating results, and financial condition. We cannot assure that we will be able to compete successfully, keep pace with, or have sufficient funds to become successful. We also cannot assure that new or other existing companies will not enter the market with lower rental costs, which could achieve greater market acceptance than the Company's facilities.

 
 
10
 
Table of Contents

 

RISKS RELATED TO THIS OFFERING

 

There has been a limited public market for our Common Stock prior to this Offering and an active market in which investors can resell their shares may not develop.

 

Prior to this Offering, there has been a limited public market for our Common Stock that trades on OTC Markets under the sybol “MEDH”. We cannot predict the extent to which an active market for our Common Stock will develop or be sustained after this Offering, or how the development of such a market might affect the market price of our Common Stock. The initial offering price of our Common Stock in this offering is based on a number of factors, including market conditions in effect at the time of the offering, and it may not be in any way indicative of the price at which our shares will trade following the completion of this offering. Investors may not be able to resell their shares at or above the initial offering price.

 

Investors in this Offering will experience immediate and substantial dilution.

 

If you purchase our Common Stock in this Offering, you will experience immediate and substantial dilution because the price you pay will be substantially greater than the net tangible book value per share of the shares you acquire. See “Dilution” and “Description of Securities” within this Offering Circular.

 

The market price of our Common Stock may fluctuate, and you could lose all or part of your investment.

 

The offering price for our Common Stock is based on a number of factors. The price of our Common Stock may decline following this Offering. The stock market in general, and the market price of our Common Stock, will likely be subject to fluctuation, whether due to, or irrespective of, our operating results, financial condition and prospects. Our financial performance, our industry’s overall performance, changing consumer preferences, technologies and advertiser requirements, government regulatory action, tax laws and market conditions in general could have a significant impact on the future market price of our Common Stock. Some of the other factors that could negatively affect our share price or result in fluctuations in our share price includes:

 

 

· actual or anticipated variations in our periodic operating results;

 

 

 

 

· increases in market interest rates that lead purchasers of our Common Stock to demand a higher yield;

 

 

 

 

· changes in earnings estimates;

 

 

 

 

· changes in market valuations of similar companies;

 

 

 

 

· actions or announcements by our competitors;

 

 

 

 

· adverse market reaction to any increased indebtedness we may incur in the future;

 

 

 

 

· additions or departures of key personnel;

 

 

 

 

· actions by stockholders;

 

 

 

 

· speculation in the press or investment community; and

 

 

 

 

· our intentions and ability to list our Common Stock on a national securities exchange and our subsequent ability to maintain such listing.

 

We do not expect to declare or pay dividends in the foreseeable future.

 

We do not expect to declare or pay dividends in the foreseeable future, as we anticipate that we will invest future earnings in the development and growth of our business. Therefore, holders of our Common Stock will not receive any return on their investment unless they sell their securities, and holders may be unable to sell their securities on favorable terms or at all.]

 
 
11
 
Table of Contents

 

Our failure to maintain effective internal controls over financial reporting could have an adverse impact on us.

 

We are required to establish and maintain appropriate internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely impact our public disclosures regarding our business, financial condition or results of operations. In addition, management's assessment of internal controls over financial reporting may identify weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting, disclosure of management's assessment of our internal controls over financial reporting or disclosure of our public accounting firm's attestation to or report on management's assessment of our internal controls over financial reporting may have an adverse impact on the price of our Common Stock.

 

Management discretion as to the actual use of the proceeds derived from this Offering.

 

The net proceeds from this Offering will be used for the purposes described under “Use of Proceeds.” However, we reserve the right to use the funds obtained from this Offering for other similar purposes not presently contemplated which we deem to be in the best interests of the Company and our shareholders in order to address changed circumstances or opportunities. As a result of the foregoing, our success will be substantially dependent upon the discretion and judgment of the Board of Directors with respect to application and allocation of the net proceeds of this Offering. Investors who purchase our Common Stock will be entrusting their funds to our Board of Directors, upon whose judgment and discretion the investors must depend.

 

The offering price of our Common Stock was arbitrarily determined and does not reflect the value of the Company, our assets or our business.

 

The offering price of our Common Stock was arbitrarily determined by our management and is not based on book value, assets, earnings or any other recognizable standard of value. We arbitrarily established the offering price considering such matters as the state of our business development and the general condition of, and opportunities present in, the industry in which we operate. No assurance can be given that our Common Stock, or any portion thereof, could be sold for the offering price or for any amount. If profitable results are not achieved from our operations, of which there can be no assurance, the value of our Common Stock sold pursuant to this Offering will fall below the offering price and become worthless. Prospective investors should not consider the offering price of the Common Stock as indicative of their actual value. The offering price bears little relationship to our assets, net worth, or any other objective criteria.

 

General securities investment risks.

 

All investments in securities involve the risk of loss of capital. No guarantee or representation is made that an investor will receive a return of its capital. The value of our Common Stock can be adversely affected by a variety of factors, including development problems, regulatory issues, technical issues, commercial challenges, competition, legislation, government intervention, industry developments and trends, and general business and economic conditions.

 

Offering not reviewed by independent professionals.

 

We have not retained any independent professionals to review or comment on this Offering or otherwise protect the interest of the investors hereunder. Although we have retained our own counsel, neither such counsel nor any other counsel has made, on behalf of the investors, any independent examination of any factual matters represented by management herein. Therefore, for purposes of making a decision to purchase our Common Stock, you should not rely on our counsel with respect to any matters herein described. Prospective investors are strongly urged to rely on the advice of their own legal counsel and advisors in making a determination to purchase our Common Stock.

 
 
12
 
Table of Contents

 

We cannot guarantee that we will sell any specific number of Common Stock shares in this Offering.

 

There is no commitment by anyone to purchase all or any part of the Common Stock Shares offered hereby and, consequently, we can give no assurance that all of the Common Stock shares in this Offering will be sold. Additionally, there is no underwriter for this Offering; therefore, you will not have the benefit of an underwriter's due diligence efforts that would typically include the underwriter being involved in the preparation of this Offering Circular and the pricing of our Common Stock shares offered hereunder. Therefore, there can be no assurance that this Offering will be successful or that we will raise enough capital from this Offering to further our development and business activities in a meaningful manner. Finally, prospective investors should be aware that we reserve the right to withdraw, cancel, or modify this Offering at any time without notice, to reject any subscription in whole or in part, or to allot to any prospective purchaser fewer Common Stock Shares than the number for which he or she subscribed.

 

We may terminate this Offering at any time during the offering period.

 

We reserve the right to terminate this Offering at any time, regardless of the number of Common Stock shares sold. In the event that we terminate this Offering at any time prior to the sale of all of the Common Stock shares offered hereby, whatever amount of capital that we have raised at that time will have already been utilized by the Company and no funds will be returned to subscribers.

 

We may be unable to meet our current and future capital requirements from capital raised by this Offering.

 

Our capital requirements depend on numerous factors, including but not limited to the rate and success of our development efforts, marketing efforts, our ability to maintain and expand our customer base, the rate of expansion of our customer base, and other factors. The capital requirements relating to the implementation of our business plan will be significant. We cannot accurately predict the timing and amount of such capital requirements. In the event that our plans change, our assumptions change or prove to be inaccurate, or if the proceeds of this Offering prove to be insufficient to implement our business plan, we would be required to seek additional financing sooner than currently anticipated. There can be no assurance that any such financing will be available to us on commercially reasonable terms, or at all. Furthermore, any additional equity financing may dilute the equity interests of our existing shareholders (including those purchasing shares pursuant to this Offering), and debt financing, if available, may involve restrictive covenants with respect to dividends, raising future capital and other financial and operational matters. If we are unable to obtain additional financing as and when needed, we may be required to reduce the scope of our operations or our anticipated business plans, which could have a material adverse effect on our business, future operating results and financial condition.

 

Directors, executive officers and principal stockholders own a significant percentage of our capital stock, and they may make decisions that you do not consider to be in your best interests or those of our other stockholders.

 

As of the date of this Offering Circular, our directors, executive officers and principal stockholders beneficially owned, in the aggregate, substantially all of our outstanding voting securities. As a result, if some or all of them acted together, they would have the ability to exert significant influence over the election of our board of directors and the outcome of issues requiring approval by our stockholders. This concentration of ownership may also have the effect of delaying or preventing a change in control of our company that may be favored by other stockholders. This could prevent transactions in which stockholders might otherwise recover a premium for their shares over current market prices.

 

The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain qualified board members.

 

As a public company, we will incur significant legal, accounting and other expenses that we have not incurred as a private company, including costs associated with public company reporting requirements. We also will incur costs associated with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Act and related rules implemented or to be implemented by the SEC. The expenses incurred by public companies generally for reporting and corporate governance purposes have been increasing. We expect the rules and regulations associated with being a public company to increase our legal and financial compliance costs and to make some activities more time-consuming and costlier, although we are currently unable to estimate these costs with any degree of certainty. These laws and regulations could also make it more difficult or costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept constraints on policy limits and coverage or incur substantially higher costs to obtain coverage. These laws and regulations could also make it more difficult for us to attract and retain qualified persons to serve on our Board, our board committees or as our executive officers and may divert management’s attention. Furthermore, if we are unable to satisfy our obligations as a public company, we could be subject to delisting of our Common Stock, fines, sanctions and other regulatory action and potentially civil litigation.]

 
 
13
 
Table of Contents

 

The preparation of our financial statements involves the use of estimates, judgments and assumptions, and our financial statements may be materially affected if such estimates, judgments or assumptions prove to be inaccurate.

 

Financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) typically require the use of estimates, judgments and assumptions that affect the reported amounts. Often, different estimates, judgments and assumptions could reasonably be used that would have a material effect on such financial statements, and changes in these estimates, judgments and assumptions may occur from period to period over time. These estimates, judgments and assumptions are inherently uncertain and, if our estimates were to prove to be wrong, we would face the risk that charges to income or other financial statement changes or adjustments would be required. Any such charges or changes could harm our business, including our financial condition and results of operations and the price of our securities. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for a discussion of the accounting estimates, judgments and assumptions that we believe are the most critical to an understanding of our consolidated financial statements and our business.

 

USE OF PROCEEDS

 

The net proceeds available for investment are estimated to be utilized by the Company to locate five areas in and around Minnesota to build self-storage facilities, as well as to fund the cost of building the facilities and working capital to run them.

 

DILUTION

 

If you purchase shares in this offering, your ownership interest in our Common Stock will be diluted immediately, to the extent of the difference between the price to the public charged for each share in this offering and the net tangible book value per share of our Common Stock after this offering.

 

Our historical net tangible book value as of December 31, 2018 was $2,140,722 or $0.016 per then-outstanding share of our Common Stock. Historical net tangible book value per share equals the amount of our total tangible assets , less total liabilities, divided by the total number of shares of our Common Stock outstanding, all as of the date specified.

 
 
14
 
Table of Contents

 

The following table illustrates the per share dilution to new investors discussed above, assuming the sale of, respectively, 100%, 75%, 50% and 25% of the shares offered for sale in this offering (after deducting estimated offering expenses of $400,000, $300,000, $200,000 and $100,000, respectively):

 

Percentage of shares offered that are sold

 

 

100%

 

 

 

75%

 

 

 

50%

 

 

 

25%

Price to the public charged for each share in this offering

 

$ 0.005

 

 

$ 0.005

 

 

$ 0.005

 

 

$ 0.005

 

Historical net tangible book value per share as of December 31, 2018 (1)

 

 

.016

 

 

 

.016

 

 

 

.016

 

 

 

.016

 

Decrease in net tangible book value per share attributable to new investors in this offering

 

 

.0544

 

 

 

0.0475

 

 

 

.0138

 

 

 

.0237

 

Net tangible book value per share, after this offering

 

 

0.0073

 

 

 

.0079

 

 

 

.0088

 

 

 

.0107

 

Dilution per share to new investors

 

 

(0.0087 )

 

 

(.0081 )

 

 

(.0072 )

 

 

(.0053 )

 

(1)

Based on net tangible book value as of December 31, 2018 of $2,140,722 and 146,616,216 outstanding shares of Common stock as of August 30, 2019.    

  
 
15
 
Table of Contents

 

MANAGEMENT'S DISCUSSION & ANALYSIS OF

FINANCIAL CONDITION & RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of our operations together with our consolidated financial statements and the notes thereto appearing elsewhere in this Offering Circular. This discussion contains forward-looking statements reflecting our current expectations, whose actual outcomes involve risks and uncertainties. Actual results and the timing of events may differ materially from those stated in or implied by these forward-looking statements due to a number of factors, including those discussed in the sections entitled “Risk Factors,” "Cautionary Statement regarding Forward-Looking Statements" and elsewhere in this Offering Circular. Please see the notes to our Financial Statements for information about our Significant Accounting Policies and Recent Accounting Pronouncements.

 

Forward Looking Statements

 

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements.” These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

 

Corporate History

 

MedX Holdings is a Wyoming corporation originally incorporated under on September 5, 2005 in the state of Colorado and was redomiciled to Wyoming effective December 28, 2015. In January 15, 2018, the Company acquired two new subsidiaries. These subsidiaries are in the business of acquiring real estate, property development, and construction of residential and commercial properties which are held for long term cash flow, or immediately sold for profit.

 

Acquisition and Change in Control

 

On January 15, 2018, the Company acquired MJ Builders of MN, LLC and DDG Properties, LLC as wholly owned subsidiaries of MedX Holdings, Inc., which exchanged 4,000,000 Preferred B Series Shares for the Companies. Simultaneous with the acquisition, Kathleen Roberton appointed Mark Miller as CEO, President, Secretary Treasurer, and Director, and resigned from those offices and as a director of the Company.

 

  Results of Operations for the Six Months Ended June 30, 2019

 

Operating Revenues

 

In the six months ended June 30, 2019 and 2018 we generated total revenue of $676,613 and $1,785,469 respectively. The decrease is due to the Company shifting the focus of its business more toward ownership and operation of rental projects and away from larger projects built for others.

 

Cost of Goods Sold

 

In the six months ended June 30, 2019 and 2018, we incurred cost of sales of $280,651 and $359,834, respectively. While economies of scale have permitted the Company to acquire materials in bulk, the Company has also relied on more subcontract labor connected with projects carried over from the prior year.

 

Gross profit

 

For the six months ended June 30, 2019 and 2018, our gross profit was $395,963 and $1,425,635, respectively. The decrease in gross profit in 2019, is due to significantly lower revenue from projects as the Company shifts its revenue model.

 
 
16
 
Table of Contents

 

Operating Expenses

 

Operating expenses for the six months ended June 30, 2019 and 2018, were $58,946 and $244,658 respectively. The decrease in operating expense during the six months ended June 30, 2019 versus 2018 is predominantly due to decreased overhead consisting of part-time employees and their associated payroll, reductions in professional fees for legal, and accounting services required for the Company to meet filing requirements, and other general and administrative costs and no additions required to the reserve for bad debts.

 

Other Expenses

 

In addition to operating expenses, during the six months ended June 30, 2019 and 2018, we incurred interest expenses of $0 and $0, non-cash loss on the change in the value of derivative instrument liability of $19,284 and $0, and the amortization of debt discount of $16,668 and $0, respectively.

 

Net Profit

 

We had a net profit of $301,065 and $1,180,977 for the six months ended June 30, 2019 and 2018, respectively.

 

Liquidity and Capital Resources

 

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

 

To date we have financed our operations through profits, sales of common stock and the issuance of debt.

 

The continuation of the Company as a going concern is dependent upon the continued financial support from its management, and its ability to identify future investment opportunities and obtain the necessary debt or equity financing and generating profitable operations from the Company’s future operations. The Company has, with several new projects on the books, and over $200,000 of cash, sufficient funds to cover its overhead and operating expenses for the coming year.

 

Working Capital

 

 

 

Six Months

Ended

June 30,

2019

 

 

Year

Ended

December 31,

2018

 

 

Percentage

Increase

(Decrease)

 

Current Assets

 

$ 1,244,000

 

 

$ 1,039,281

 

 

 

19.6 %

Current Liabilities

 

$ 218,348

 

 

$ 317,968

 

 

 

(31.3 )%

Working Capital Surplus (Deficit)

 

$ 1,025,652

 

 

$ 721,313

 

 

 

42.1 %

  
 
17
 
Table of Contents

 

At June 30, 2019, our cash balance was $567,001 compared to $218,388 at December 31, 2018. The increase in cash is attributed to an increase in profitable revenue .

 

At June 30, 2019, we had total current liabilities of $218,348 , compared with total current liabilities of $317,968 at December 31, 2018. The decrease in current liabilities is attributed to reduction of notes payable.

 

At June 30, 2019, we had a working capital surplus of $1,025,652 compared with a working capital surplus of $721,313 at December 31, 2018. The increase in working capital surplus is primarily due to an increase in profitable revenue, an increase in accounts receivable, and decreases in notes payable offset with cash obtained from proceeds of a convertible note.

 

Cash Flows

 

 

 

For the Six Months Ended June 30,

 

 

Percentage

Increase

 

 

 

2019

 

 

2018

 

 

(Decrease)

 

Cash Provided by Operating Activities

 

$ 487,010

 

 

$ 371,458

 

 

 

31.1 %

Cash Provided by Investing Activities

 

 

--

 

 

 

4,311

 

 

 

-%

 

Cash Provided (Used) by Financing Activities

 

 

(138,397 )

 

 

273,022

 

 

 

(150.7 )%

Net Increase (Decrease) in Cash

 

 

348,613

 

 

 

648,791

 

 

 

46.3 %

 

Cash flow from Operating Activities

 

During the six months ended June 30, 2019, we provided $487,010 of cash in operating activities compared to $1,119,888 of cash from operating activities during the period ended June 30 , 2018. The decrease in cash provided from operating activities was mainly attributed to a decrease in Net Profit which was approximately $879,912 less than the prior year period.

 

Cash flow from Investing Activities

 

During the six months ended June 30, 2019 and 2018, we used $0 and generated $411,311, respectively, from investing activities.

 

Cash flow from Financing Activities

 

During the six months ended June 30, 2019 and 2018, Net Cash used was $138,397 in 2019 and Net Cash provided was $119,302 from financing activities. The cash used in financing activities for the period ended June 30 , 2019 are attributed to $138,397 used in the repayment of term notes.

 

Results of Operations for the Year Ended December 31, 2018

 

Summary of Results

 
 
18
 
Table of Contents

 

The following table summarizes the results of our operations for the year ended December 31, 2018.

 

 

 

December 31,

2018

 

 

December 31,

2017

 

Rental income

 

$ 886,758

 

 

$ 51,947

 

Project income

 

 

1,289,170

 

 

 

672,876

 

Total Revenues

 

 

2,175,928

 

 

 

724,823

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

549,031

 

 

 

239,896

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

1,626,897

 

 

 

484,926

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

711,807

 

 

 

57,087

 

 

 

 

 

 

 

 

 

 

Profit from operations

 

 

915,090

 

 

 

427,839

 

 

 

 

 

 

 

 

 

 

Total other income / (expense)

 

 

(18,535 )

 

 

(1,780 )

 

 

 

 

 

 

 

 

 

Net profit (loss) applicable to common stock holders

 

$ 896,555

 

 

$ 426,059

 

 

Operating Revenues

 

  During the years ended December 31, 2018 and 2017 we generated total revenue of $2,175,928 and $724,823 respectively, an increase of approximately 200%. For the year ended December 31, 2018 and 2017 we generated rental income of $886,758 and $51,947, respectively, and revenue from construction projects of $1,289,170 and $672,876, respectively. The increases is due to the Company being awarded more projects, as well as an increase in rental income from projects completed during the prior year.

 

Cost of Goods Sold

 

During the years ended December 31, 2018 and 2017, we incurred cost of sales of $549,031 and $239,896, respectively an increase of approximately 129.9%. The increase of cost of goods sold is commensurate with the increase of total revenues and reflects certain economies of scale.

 

Gross profit

 

For the years ended December 31, 2018 and 2017, our gross profit was $1,626,897 and $484,926, respectively. The increase in gross profit in 2018, is due to significantly higher revenue and proportionally lower costs of goods sold.

 

Net Profit

 

For the years ended December 31, 2018 and 2017, we had Net Profits of 896,555 and 426,059 respectively.

 

Operating Expenses

 

Our operating expenses for the years ended December 31, 2018 and 2017 are outlined in the table below:

 

 

 

Years Ended

 

 

 

December 31,

 

 

 

2018

 

 

2017

 

General and administrative

 

$ 711,807

 

 

$ 57,087

 

Total

 

$ 711,807

 

 

$ 57,087

 

 

Operating expenses for the years ended December 31, 2018 and 2017, were $711,807 and $57,087 respectively. The increase in operating expense during the years ended December 31, 2018 versus 2017 is predominantly due to increased overhead consisting of part-time employees and their associated payroll, professional fees for legal, and accounting services required for the Company to meet filing requirements, and other general and administrative costs such as $450,000 reserve for bad debts, due to the additional workload brought about by the increase in business, offset by some reductions in 2018 due to less overhead required for the work.

 

Other Expenses

 

In addition to operating expenses, we incurred interest expenses of $225 and $1,780 during the year ended December 31, 2018 and 2017, respectively. The decrease in interest expense during the year ended December 31, 2018 is primarily attributable to the conversion of several convertible debentures being converted into equity during the year.

 

Notes Receivable

 

For the period ended December 31, 2018, the Company had notes receivable of $1,194,223 with a reserve for bad debts in the amount of $450,000. Of the $744,223 net loans receivable at December 31, 2018, the Company has collected approximately 42% and continues to work with these suppliers and contractors to either be repaid or work the balance off through current projects.

 

The Company evaluates the collectability of these receivables on a quarterly basis to determine if the reserve for bad loans should be adjusted based on their collectability.

 

 
19
 
Table of Contents

 

Liquidity, Capital Resources and Plan of Operations

 

At December 31, 2018, we had a working capital surplus of $721,313 compared with a working capital deficit of $199,682 at December 31, 2017. The increase in working capital surplus is primarily due to an increase in profitable revenue, an increase in prepaid expenses, and decreases in accounts payable and accrued expenses offset with cash obtained from proceeds of notes.

 

We have sufficient cash flow to maintain our operations at their current state for the next 12-months. However, in order to implement out plan of operations as set forth below, the Company will need to raise additional capital. We believe the capital raised from the current offering will be sufficient for us to implement our plan or operation. However, if we are unable to raise the maximum amount in this offering or if it takes longer to raise such capital than anticipated we may have to forgo certain plans and scale back our rollout.

 

Income Taxes

 

Prior to January 2018, when current management took over upon the acquisition of two construction companies, the Company generated cumulative loses. The two construction companies acquired are limited liability companies, and until they were acquired by the Company each LLC would issue a K-1 which would be included on the prior owner’s tax filings with the IRS. As a result, the LLC’s do not show any prior taxes or liabilities due to their tax nature. As of January 2018, they became wholly owned subsidiaries of MedX Holdings, Inc. (MedX holds 100% of the membership interests in the two subsidiary LLC’s) and will be filing with MedX on a consolidated basis.

 

Current Plan of Operations

 

Over the next 12 months we intend to shift the Company’s focus from buying, rehabbing and renting properties to developing self-storage facilities. The Company believes that the self-storage market has a number of attributes that make it superior to the Company’s current focus, including:

 

 

· Storage facilities are easy to manage and require very little staff

 

· The manager is able to handle all the building of the facilities keeping startup costs low

 

· The company has already located five potential areas in the greater MN area in need of storage facilities.

 

· The facilities can be built as capital is raised

  

The timing of completion of any aspect of our plan of operations is highly dependent on the availability of cash to implement that aspect of the plan and other factors beyond our control. There is no assurance that we will successfully obtain the required capital or revenues, or, if obtained, that the amounts will be sufficient to fund our ongoing operations. The inability to secure additional capital would have a material adverse effect on us, including the possibility that we would have to sell or forego a portion or all of our assets or cease operations. If we discontinue our operations, we will not have sufficient funds to pay any amounts to our stockholders.

 

Credit Facilities and Accounts Payable

 

We do not maintain any credit facilities at this time, but have notes payable of $271,439.

 

Off-Balance Sheet Arrangements

 

We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements.

 

Quantitative and Qualitative Disclosures about Market Risk

 

In the ordinary course of our business, we are not exposed to market risk of the sort that may arise from changes in interest rates or foreign currency exchange rates, or that may otherwise arise from transactions in derivatives.

 

Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company's management, in consultation with its legal counsel as appropriate, assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company, in consultation with legal counsel, evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is probable, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.

 
 
20
 
Table of Contents

 

Relaxed Ongoing Reporting Requirements

 

Upon the completion of this Offering, we may elect to become a public reporting company under the Exchange Act. If we elect to do so, we will be required to publicly report on an ongoing basis as an “emerging growth company” (as defined in the Jumpstart Our Business Startups Act of 2012, which we refer to as the “JOBS Act”) under the reporting rules set forth under the Exchange Act. As defined in the JOBS Act, an emerging growth company is defined as a company with less than $1.0 Billion in revenue during its last fiscal year. An emerging growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies.

 

For so long as we remain an “emerging growth company,” we may take advantage of certain exemptions from various reporting requirements that are applicable to other Exchange Act reporting companies that are not “emerging growth companies,” including but not limited to:

 

 

· not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;

 

 

 

 

· taking advantage of extensions of time to comply with certain new or revised financial accounting standards;

 

 

 

 

· being permitted to comply with reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and

 

 

 

 

· being exempt from the requirement to hold a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

If we are required to publicly report under the Exchange Act as an “emerging growth company”, we expect to take advantage of these reporting exemptions until we are no longer an emerging growth company. We would remain an “emerging growth company” for up to five years, though if the market value of our Common Stock that is held by non-affiliates exceeds $700 million, we would cease to be an “emerging growth company”.

 
 
21
 
Table of Contents

 

OUR BUSINESS

 

Organization Overview

 

MedX Holdings Inc. was incorporated on September 5, 2006 as Disaboom, Inc. under the laws of the state of Colorado. The Company redomiciled in the state of Wyoming on December 28, 2015, at which time it was known as Cantor Group Inc. The Company changed its name to MedX Holdings in February 2016.

 

The Company operates through its subsidiaries MJ Builders of MN, LLC, a Minnesota limited liability corporation and DDG Properties, LLC, a Minnesota limited liability corporation. MJ Builders builds commercial and residential properties and is licensed in the state of Minnesota. DDG manages properties for rent. The Company has also created MJ Storage MN, LLC, a Minnesota limited liability corporation that will build and manage self-storage facilities. The Company has discontinued its previous operations and is focusing soley on its real estate subsidiaries.

 

MJ Builders of MN, LLC. was started in February of 2017 in Minnesota and grew out of a previous construction company owned by the Company’s CEO who has been a licensed General Contractor in the state of Minnesota for 12 years and has been a private construction contractor since May 2001.

 

DDG Properties, LLC was started in June 2011. DDG started with 9 Properties that were all single family homes. The principals of DDG used their construction experience to take distressed homes and turn them into renovated cash flow producing assets. DDG has since grown rapidly owning both commercial and residential properties. Some of the property DDG owns is land for future development.

 

Business Strategy

 

Over the next 12 months we intend to shift the Company’s focus from buying, rehabbing and renting properties to developing self-storage facilities.

 

The Company, though MJ Storage, will develop and build the storage facilities as well as manage them. The company believes they have an advantage over other companies looking to get into the same industry, due to the expertise of CEO Mark Miller and the experience of MJ Builders of MN Construction. MJ Builders is a mid-level development and construction company that has been in business seventeen years and has developed a multitude of projects ranging from building houses, offices and retail facilities. Being able to handle the building of the storage facilities and not needing to hire an outside construction company will save the company on various costs. Keeping the start up costs low will enable the company to reach profitability much faster.

 

The Company has decided to transition from its current business plan as the development and management of storage facilities provide certain advantages such as:

 

 

· Storage facilities are easy to manage and require very little staff

 

· The manager is able to handle all the building of the facilities keeping startup costs low

 

· The company has already located five potential areas in the greater MN area in need of storage facilities.

 

· The facilities can be built as capital is raised.

 

The Company’s storage facilities will have a variety of self storage sizes. It is expected that the typical facility will have the following sizes of units and monthly rental prices a:

 

No. Of Units

Unit Size

Monthly Rental

48

4 x 7

$49

75

10 x 10

$89

54

10 x 20

$119

27

10 x 30

$149

 
 
22
 
Table of Contents

 

Additionally, MJ Storage will offer exterior storage on expandable property for storing boats during the winter months. This can be a big source of revenue so storage facilities in many northern states as boat owners usually don’t want to tow big boats hundreds of miles to the lakes and back. Instead they would rather pay to have it kept at a storage facility near the lake until its needed the following year.

 

Renters of the storage units can opt to sign a one-year lease for a discount on the monthly fee. All renters pay a security deposit and key deposit at the time they first rent the unit. Rental fees are owed by the fifth of every month (Automatically charged or billed electronically), and in the event a rental fee is not paid a lien can be placed on the contents of the storage unit and can be sold to recover the fees owed once the rental fees are over thirty days past due.

 

The facility will allow customers twenty-four hour a day access to their unit. An armed guard will be present at all times on the facility as well as at least one staff member in the front office. A coded key is needed to gain access to the facility which logs which person entered the facility and at what time, as well as the time they leave. Closed circuit cameras will be set up all over the facility monitoring every person’s actions except in the privacy of their own storage unit.

 

As another source of revenue, as well as convenience for customers, the front office will also sell moving supplies such as different size boxes, packing supplies such as tape, bubble wrap, foam peanuts and plastic covers for mattresses and other furniture. Customers will be required to provide their own pad locks for their units which they can also purchase from our store.

 

Our design calls for each storage facility to have six buildings totaling 204 Units of various sizes with additional land space available for future expansion or outside storage.

 

The buildings are made to withstand winds up to 115 MPH with the roof being able to manage 30 lbs of snowfall on them. We estimate that each facility will cost $420,000. The cost of the actual buildings including the acquisition of the property is $270,000 with $150,000. Each facility can be built in three to four months weather permitting.

 

Employees

 

1

 

Property

 

The Company owns 9 single family homes and approximately 132 acres of commercial land outside of Minneapolis, Minnesota.

 
 
23
 
Table of Contents

 

DIRECTORS, EXECUTIVE OFFICERS & CORPORATE GOVERNANCE

 

The following is a list of our currently active, interim, and planned executive officers and directors and their respective ages and positions as of the date of this Offering Circular. Some of the officers listed below are currently engaged on a part-time or interim basis, however, it is the Company’s intent that all of the officers listed below will become full-time officers upon the successful completion of this Offering.

 

Name

 

Position

 

Term of Office

Executive Officers:

 

Mark Miller

 

CEO

 

Since January 28, 2018

 

 

Directors:

 

Mark Miller

 

Director

 

Since January 28, 2018

 

During the past five (5) years, none of the persons identified above has been involved in any bankruptcy or insolvency proceeding or convicted in a criminal proceeding, excluding traffic violations and other minor offenses. There is no arrangement or understanding between the persons described above and any other person pursuant to which the person was selected to his or her office or position.

 

Executive Officers and Directors

 

Mark Miller, CEO and Director

 

Mark Miller is the founder MJ Builders of MN, LLC a wholly owned subsidiary of MedX Holdings, Inc. a full service construction company based in Minnesota. MJ Builders of MN, LLC. has been in business seventeen years and during that time has worked on dozens of projects ranging in size from $200k to $2 million. This includes building houses from start to finish as well as office buildings and industrial buildings.

 

Term of Office

 

Directors serve until the next annual meeting and until their successors are elected and qualified. Officers are appointed to serve for one (1) year until the meeting of the Board following the annual meeting of shareholders and until their successors have been elected and qualified.

 

Director Independence

 

We use the definition of “independence” of The NASDAQ Stock Market to make this determination. NASDAQ Listing Rule 5605(a)(2) provides that an “independent director” is a person other than an officer or employee of the company or any other individual having a relationship which, in the opinion of the Company’s Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The NASDAQ listing rules provide that a director cannot be considered independent if:

 

 

· the director is, or at any time during the past three (3) years was, an employee of the company;

 

· the director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period of twelve (12) consecutive months within the three (3) years preceding the independence determination (subject to certain exemptions, including, among other things, compensation for board or board committee service);

 

· the director or a family member of the director is a partner in, controlling shareholder of, or an executive officer of an entity to which the company made, or from which the company received, payments in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exemptions;

 

· the director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three (3) years, any of the executive officers of the company served on the compensation committee of such other entity; or

 

· the director or a family member of the director is a current partner of the company’s outside auditor, or at any time during the past three (3) years was a partner or employee of the company’s outside auditor, and who worked on the company’s audit.

 

 
24
 
Table of Contents

 

Under such definitions, we have no independent directors. However, our Common Stock is not currently quoted or listed on any national exchange or interdealer quotation system with a requirement that a majority of our Board be independent and, therefore, the Company is not subject to any director independence requirements.

 

Family Relationships

 

There are no family relationships among any of our officers or directors.

 

Involvement in Certain Legal Proceedings

 

Except as disclosed below, to our knowledge, none of our current directors or executive officers has, during the past ten (10) years:

 

·

been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

·

had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two (2) years prior to that time;

 

·

been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

 

·

been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

 

·

been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

·

been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.]

 

Code of Business Conduct and Ethics

 

Our Board plans to adopt a written code of business conduct and ethics (“Code”) that applies to our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. We intend to post on our website a current copy of the Code and all disclosures that are required by law in regard to any amendments to, or waivers from, any provision of the Code.

 
 
25
 
Table of Contents

 

EXECUTIVE COMPENSATION

 

The following table represents information regarding the total compensation our executive officers and director of the Company as of December 31, 2018:

 

 

 

Cash

 

 

Other

 

 

Total

 

Name and Principal Position

 

Compensation

 

 

Compensation

 

 

Compensation

 

 

($)

 

 

($)

 

 

($)

 

 

 

 

 

 

 

 

 

 

 

Mark Miller, CEO

 

$ 0

 

 

$ 0

 

 

$ 0

 

 

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

 

Transactions with Related Persons

 

On March 31, 2017, the Company and Kathleen Roberton, its CEO at the time, agreed to exchange $ 165,000 in unpaid salary and $23,79.75 owed to Kathleen Roberton for 72,917,200 shares of common stock. The shares of common stock exchange at a price of $0.0025 which represents approximately 50% of the bid, par value $0.001.

 

On January 15, 2018 4,000,000 Series B Preferred shares were issued to Mark Miller, the Company’s CEO and sole director, for the acquisition of MJ Builders of MN, LLC. And DDG Properties, LLC. The preferred shares exchange at a price of $0.25 per share.

 

On March 10, 2018, former CEO Kathleen Roberton, sold to then CEO Mark Miller, 98,117,200 shares of restricted common stock. Mr. Miller subsequently assigned 5,000,000 shares to a third party in exchange for certain assets in a private transaction.

 

SECURITY OWNERSHIP OF MANAGEMENT & CERTAIN SECURITYHOLDERS

 

Class

Name

Number of Shares

Direct or Indirect

Percentage of Class

Common Shares

Mark Miller, CEO/Director

93,117,200

Direct

63.5% (1)

 

Series B Preferred

Mark Miller, CEO/Director

4,000,000

Direct

100%

  

(1) Based upon 146,616,216 shares of Common Stock issued and outstanding as of August 30, 2019

 

DESCRIPTION OF SECURITIES

 

The following is a summary of the rights of our capital stock as provided in our certificate of incorporation, bylaws and certificate of designation. For more detailed information, please see our certificate of incorporation, bylaws and certificate of designation which have been filed as exhibits to the Offering Statement of which this Offering Circular is a part.

 

General

 

The Company is authorized to issue 1,000,000,000 (One Billion) shares of Common Stock par value $.001 per share. We have 146,616,216 shares issued and outstanding as of August 30, 2019.

 
 
26
 
Table of Contents

 

Our Common Shares will be, when issued against full payment of the purchase price therefor, fully paid and nonassessable. Our Common Shares do not carry any preemptive rights enabling a holder to subscribe for or receive any additional securities that we may issue from time to time. No conversion rights, redemption rights or sinking fund provisions are applicable to our Common Shares. The rights of holders of Common Shares will be subject to the rights of holders of any Preferred Shares and any Preference Shares that may be issued and outstanding from time to time. Our Board of Directors can authorize the issuance of Preferred Shares and Preference Shares without shareholder approval. Such issued shares could have voting, conversion and other rights that could adversely affect the rights of holders of Common Shares. Our Board of Directors also could authorize the issuance of additional Common Shares from time to time without shareholder approval.

 

Dividends

 

The holders of our Common Shares are entitled to receive such dividends as may be declared by our Board of Directors out of funds legally available for distribution. These dividends may be paid only out of funds remaining after full cumulative dividends upon all outstanding Preferred Shares and Preference Shares have been paid or set apart for payment for all past dividend periods and the then current dividend period.

 

Liquidation Rights

 

Upon any voluntary or involuntary liquidation of Weyerhaeuser, our assets must be used in the following order of priority:

 

 

· payment of or provision for all of our debts and liabilities;

 

· payment of all sums to which the Preferred Shares or Preference Shares may be entitled; and

 

· distribution ratably to holders of our Common Shares the remaining assets of the Company.

 

Voting Rights

 

The holders of Common Shares currently possess exclusive voting rights on all matters submitted to our shareholders. However, our Board of Directors may also specify other voting rights with respect to Preferred Shares or Preference Shares that may be issued in the future. Each holder of Common Shares is entitled to one vote per share with respect to all matters. There is no cumulative voting in the election of directors, which means that the holders of a majority of the shares entitled to vote for the election of our directors can elect all of our directors then standing for election.

 

Changes in Authorized Number

 

The number of authorized shares of Common Stock may be increased or decreased subject to the Company’s legal commitments at any time and from time to time to issue them, by the affirmative vote of the holders of a majority of the stock of the Company entitled to vote.

 

Preferred Stock

 

Series A Preferred

 

3,000,000 shares of preferred stock are designated as “Series A Convertible Preferred Stock.” 400,000 shares of Series A Convertible Preferred Stock are issued and outstanding as of August 30, 2019.

 

Voting

 

The holders of outstanding shares of Series A Preferred Stock shall be entitled to notice of any shareholders’ meeting and to vote as a single class with the Common Stock upon any matter submitted for approval by the holders of Common Stock. Each share of Series A Preferred Stock shall have fifty votes per share.

 
 
27
 
Table of Contents

 

Dividends

 

Commencing on the date of the issuance of any shares of Series A Preferred Stock, the Corporation shall accrue on each outstanding share of Series A Preferred Stock a cumulative dividend (the “Dividend”), at an annual rate equal of 15%. The Dividend shall be payable when, and if declared, based on the numbers of shares of Series A Preferred Stock outstanding as of the date such dividend is declared. No dividends or distributions shall be payable with respect to any other series of Preferred Stock or with respect to any shares of Common Stock unless all accrued Dividends have been paid to the holders of the Series A Preferred Stock.

 

Liquidation

 

Holders of the Series A Preferred Stock shall be entitled to receive out of the assets of the Corporation, whether such assets are capital or surplus, for each share of Series A Preferred Stock an amount equal to $1.00 per share of the Series A Preferred Stock (as adjusted for stock splits and combinations, stock dividends, reclassifications and the like) plus any accrued and unpaid dividends thereon (the “Series A Liquidation Preference”) before any distribution or payment shall be made to the holders of any Common Stock or equity equivalent securities of the Corporation that rank pari passu with the Common Stock.

 

DIVIDEND POLICY

 

We plan to retain any earnings for the foreseeable future for our operations. We have never paid any dividends on our Common Stock and do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay cash dividends will be at the discretion of our Board and will depend on our financial condition, operating results, capital requirements and such other factors as our Board deems relevant.

 

PLAN OF DISTRIBUTION

 

The shares are being offered by us on a “best-efforts” basis by our officers, directors and employees, with the assistance of independent consultants, and possibly through registered broker-dealers who are members of the Financial Industry Regulatory Authority (“FINRA”) and finders. As of the date of this Offering Circular, unless otherwise permitted by applicable law, we do not intend to accept subscriptions from investors in this Offering who reside in certain states, unless and until the Company has complied with each such states’ registration and/or qualification requirements or a FINRA-member broker-dealer has been engaged by the Company to consummate and process sales to investors in such states. We reserve the right to temporarily suspend and/or modify this Offering and Offering Circular in the future, during the Offering Period, in order to take such actions necessary to enable the Company to accept subscriptions in this Offering from investors residing in such states identified above.

 

There is no aggregate minimum to be raised in order for the Offering to become effective and therefore the Offering will be conducted on a “rolling basis.” This means we will be entitled to begin applying “dollar one” of the proceeds from the Offering towards our business strategy, offering expenses, reimbursements, and other uses as more specifically set forth in the “Use of Proceeds” contained elsewhere in this Offering Circular.

 

We may pay selling commissions to participating broker-dealers who are members of FINRA for shares sold by them, equal to a percentage of the purchase price of the Common Stock shares. We may pay finder’s fees to persons who refer investors to us. We may also pay consulting fees to consultants who assist us with the Offering, based on invoices submitted by them for advisory services rendered. Consulting compensation, finder’s fees and brokerage commissions may be paid in cash, Common Stock or warrants to purchase our Common Stock. We may also issue shares and grant stock options or warrants to purchase our common stock to broker-dealers for sales of shares attributable to them, and to finders and consultants, and reimburse them for due diligence and marketing costs on an accountable or non-accountable basis. We have not entered into selling agreements with any broker-dealers to date, though we may engage a FINRA registered broker-dealer firm for offering administrative services. Participating broker-dealers, if any, and others may be indemnified by us with respect to this offering and the disclosures made in this Offering Circular.]

 

Our Offering will expire on the first to occur of (a) the sale of all 500,000,000 shares of Common Stock offered hereby, (b) 1 year from the date that this Offering Circular is declared effective, subject to extension for up to one hundred-eighty (180) days in the sole discretion of the Company, or (c) when our board of directors elects to terminate the Offering.

 
 
28
 
Table of Contents

 

ADDITIONAL INFORMATION ABOUT THE OFFERING

 

Offering Period and Expiration Date

 

This Offering will start on or immediately prior to the date on which the SEC initially qualifies this Offering Statement (the “Qualification Date”) and will terminate on the Termination Date (the “Offering Period”).

 

Procedures for Subscribing

 

If you decide to subscribe for our Common Stock shares in this Offering, you should:

 

1.

Electronically receive, review, execute and deliver to us a subscription agreement; and

 

2.

Deliver funds directly by wire or electronic funds transfer via ACH to the Company’s bank account designated in the Company’s subscription agreement.

 

Any potential investor will have ample time to review the subscription agreement, along with their counsel, prior to making any final investment decision. We shall only deliver such subscription agreement upon request after a potential investor has had ample opportunity to review this Offering Circular.

 

Right to Reject Subscriptions

 

After we receive your complete, executed subscription agreement and the funds required under the subscription agreement have been transferred to our designated account, we have the right to review and accept or reject your subscription in whole or in part, for any reason or for no reason. We will return all monies from rejected subscriptions immediately to you, without interest or deduction.

 

Acceptance of Subscriptions

 

Upon our acceptance of a subscription agreement, we will countersign the subscription agreement and issue the shares subscribed at closing. Once you submit the subscription agreement and it is accepted, you may not revoke or change your subscription or request your subscription funds. All accepted subscription agreements are irrevocable.

 

LEGAL MATTERS

 

Certain legal matters with respect to the shares of Common Stock offered hereby will be passed upon by Jonathan D. Leinwand, P.A., Aventura, Florida.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a Regulation A Offering Statement on Form 1-A under the Securities Act of 1993, as amended, with respect to the shares of Common Stock offered hereby. This Offering Circular, which constitutes a part of the Offering Statement, does not contain all of the information set forth in the Offering Statement or the exhibits and schedules filed therewith. For further information about us and the Common Stock offered hereby, we refer you to the Offering Statement and the exhibits and schedules filed therewith. Statements contained in this Offering Circular regarding the contents of any contract or other document that is filed as an exhibit to the Offering Statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the Offering Statement. Upon the completion of this Offering, we will be required to file periodic reports, proxy statements, and other information with the SEC pursuant to the Securities Exchange Act of 1934. You may read and copy this information at the SEC's Public Reference Room, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, including us, that file electronically with the SEC. The address of this site is www.sec.gov.

 
 
29
 
Table of Contents

 

Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this offering statement to be signed on behalf by the undersigned, thereunto duly authorized, in Pequot Lakes, State of Minnesota, on June 26, 2019.

 

  MedX Holdings Inc.
       
By: /s/ Mark Miller

 

 

Mark Miller  
    Principal Executive Officer,  
    Principal Accounting Officer  

 

 
30
 
Table of Contents

 

Part III – EXHIBITS

 

Exhibit No.

 

Description

 

2.1

 

Articles of Incorporation

2.2

 

2009 Articles of Amendment

2.3

 

Articles of Domestication - Wyoming

2.4

 

Articles of Amendment – May 9, 2017

2.5

 

Articles of Amendment – June 20, 2019

2.6

 

Bylaws of MedX Holdings Inc.

4.1

 

Form of Subscription Agreement

11.1

 

Consent of Jonathan D. Leinwand, P.A. (contained in Exhibit 12.1)

12.1

 

Opinion of Jonathan D. Leinwand, P.A.

 

 
31
 
Table of Contents
                  

Unaudited Balance Sheets at June 30, 2019 and December 31, 2018

F-2

 

 

Unaudited Statements of Operations for the six months ended June 30, 2019 and 2018

F-3

 

 

Unaudited Statements of Stockholders Equity for the six months ended June 30, 2019 and the year ending December 31, 2018

F-4

 

 

Unaudited Consolidated Statements of Cash Flows for the six months ended June 30, 2019 and 2018

F-5

 

 

Notes to the Unaudited Consolidated Financial Statements

F-6 to F-12

 
 
F-1
 
Table of Contents

 

MEDEX Holdings, Inc.
BALANCE SHEETS
(Unaudited)

 

 

 

June 30,

 

 

December 31,

 

 

 

2019

 

 

2018

 

ASSETS

Current assets:

 

 

 

 

 

 

Cash

 

$ 567,001

 

 

$ 218,388

 

Accounts receivable (net of reserve for bad debts of $0 and $0, respectively)

 

 

69,626

 

 

 

48,120

 

Loans receivable (net of reserve for bad debts of $450,000 and $450,000, respectively)

 

 

578,823

 

 

 

744,223

 

Prepaid expenses - current

 

 

28,550

 

 

 

28,550

 

Total current assets

 

 

1,244,000

 

 

 

1,039,281

 

 

 

 

 

 

 

 

 

 

Fixed and intangible assets:

 

 

 

 

 

 

 

 

Capital assets

 

 

146,000

 

 

 

146,000

 

Rental properties

 

 

227,860

 

 

 

230,209

 

Equipment

 

 

26,250

 

 

 

30,000

 

Intangible assets

 

 

200

 

 

 

200

 

Fixed and intangible assets, net

 

 

400,310

 

 

 

406,409

 

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

 

Investment in subsidiaries

 

 

1,000,000

 

 

 

1,000,000

 

Capitalized Re-Organization costs

 

 

13,000

 

 

 

13,000

 

Total other assets

 

 

1,013,000

 

 

 

1,013,000

 

 

 

 

 

 

 

 

 

 

Total assets

 

$ 2,657,310

 

 

$ 2,458,690

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS DEFICIT

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$ 3,219

 

 

$ 3,219

 

Notes payable

 

 

133,042

 

 

 

271,439

 

Convertible promissory notes (net of debt discount of $5,554 and $22,222, respectively)

 

 

22,271

 

 

 

2,778

 

Derivative instrument liability

 

 

59,816

 

 

 

40,532

 

Total current liabilities

 

 

218,348

 

 

 

317,968

 

 

 

 

 

 

 

 

 

 

Total long-term liabilities

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

28,348

 

 

 

317,968

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Stockholders' deficit

 

 

 

 

 

 

 

 

Preferred stock Series A - $0.001 par value, authorized - 3,000,000 shares; issued and outstanding 400,000 and 400,000 respectively

 

 

400

 

 

 

400

 

Preferred stock Series B - $0.001 par value, authorized - 4,000,000 shares; 4,000,000 and 4,000,000 shares issued and outstanding, respectively

 

 

4,000

 

 

 

4,000

 

Common Stock - $0.001 par value; 200,000,000 shares authorize; issued and outstanding 146,911,216 and 133,611,216 shares, respectively

 

 

146,911

 

 

 

133,611

 

Additional paid-in capital

 

 

500,117

 

 

 

516,242

 

Accumulated retained earnings

 

 

1,787,534

 

 

 

1,486,469

 

Total stockholders' deficit

 

 

2,438,962

 

 

 

2,140,722

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' deficit

 

$ 2,657,310

 

 

$ 2,458,690

 

  

See accompanying notes to the financial statements

 

 
F-2
 
Table of Contents

 

MEDX Holdings, Inc.

STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

For the three months ended

 

 

For the six months ended

 

 

 

June 30,
2019

 

 

June 30,
2018

 

 

June 30,
2019

 

 

June 30,
2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental income

 

$ 209,789

 

 

$ 204,289

 

 

$ 413,578

 

 

$ 405,988

 

Project income

 

 

195,514

 

 

 

1,153,800

 

 

 

263,035

 

 

 

1,379,480

 

Total Revenues

 

 

405,303

 

 

 

1,358,090

 

 

 

676,613

 

 

 

1,785,469

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

131,493

 

 

 

337,893

 

 

 

274,552

 

 

 

349,708

 

Insurance

 

 

(489 )

 

 

897

 

 

 

6,099

 

 

 

10,127

 

Cost of sales

 

 

131,004

 

 

 

338,790

 

 

 

280,651

 

 

 

359,834

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

274,300

 

 

 

1,019,301

 

 

 

395,963

 

 

 

1,425,635

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

8,883

 

 

 

128,090

 

 

 

58,946

 

 

 

244,658

 

Total operating expenses

 

 

8,883

 

 

 

128,090

 

 

 

58,946

 

 

 

244,658

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit from operations

 

 

265,417

 

 

 

891,211

 

 

 

337,017

 

 

 

1,180,977

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income / (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain (Loss) on change in value of derivative liability

 

 

15,884

 

 

 

-

 

 

 

(19,284 )

 

 

-

 

Amortization of debt discount

 

 

(8,334 )

 

 

-

 

 

 

(16,668 )

 

 

-

 

Total other income / (expense)

 

 

7,550

 

 

 

-

 

 

 

(35,952 )

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit (loss) applicable to common stockholders

 

$ 272,967

 

 

$ 891,211

 

 

$ 301,065

 

 

$ 1,180,977

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per share data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Profit per share - basic and diluted

 

$ 0.00

 

 

$ 0.01

 

 

$ 0.00

 

 

$ 0.01

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding- basic and diluted

 

 

137,703,524

 

 

 

112,611,216

 

 

 

135,668,675

 

 

 

114,641,216

 

 

See accompanying notes to the financial statements

 

  
F-3
Table of Contents

 

MEDX Holdings, Inc.

STATEMENTS OF STOCKHOLDERS' EQUITY

(Unaudited)

 

 

 

Preferred A Series Stock

 

 

Preferred B Series Stock

 

 

Common Stock

 

 

Additional

 

 

 

 

 

Total

 

 

 

($0.001 par value)

 

 

($0.001 par value)

 

 

($.001 par value)

 

 

Paid-In

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2018

 

 

400,000

 

 

$ 400

 

 

 

-

 

 

$ -

 

 

 

112,611,216

 

 

$ 112,611

 

 

$ 611,740

 

 

$ (494,856 )

 

$ 229,895

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of stock for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of debentures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21,000,000

 

 

 

21,000

 

 

 

(6,729 )

 

 

 

 

 

 

14,271

 

Correction - rounding error

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

Shares issued for acquisition of MJ Holdings, Inc.

 

 

 

 

 

 

 

 

 

 

4,000,000

 

 

 

4,000

 

 

 

 

 

 

 

 

 

 

 

(88,769 )

 

 

1,084,769

 

 

 

1,000,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

896,555

 

 

 

896,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2018

 

 

400,000

 

 

 

400

 

 

 

4,000,000

 

 

 

4,000

 

 

 

133,611,216

 

 

 

133,611

 

 

 

516,242

 

 

 

1,486,469

 

 

 

2,140,722

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of stock for:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of debentures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13,300,000

 

 

 

13,300

 

 

 

(16,125 )

 

 

 

 

 

 

(2,825 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

301,065

 

 

 

301,065

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, June 30, 2019

 

 

400,000

 

 

$ 400

 

 

 

4,000,000

 

 

$ 4,000

 

 

 

146,911,216

 

 

$ 146,911

 

 

$ 500,117

 

 

$ 1,787,534

 

 

$ 2,438,962

 

  

See accompanying notes to the financial statements

 

 
F-4
 
Table of Contents

 

MEDX Holdings, Inc.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

For the six months ended

 

 

 

June 30,
2019

 

 

June 30,
2018

 

Cash flows from operating activities:

 

 

 

 

 

 

Net profit (loss)

 

$ 301,065

 

 

$ 1,180,977

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

6,099

 

 

 

-

 

Preferred stock issued for services

 

 

-

 

 

 

4,000

 

Amortization of debt discount

 

 

16,668

 

 

 

-

 

Change in fair value of derivative liability

 

 

19,284

 

 

 

-

 

Changes in operating asset and liability account balances:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(21,506 )

 

 

(17,534 )

Loans receivable

 

 

165,400

 

 

 

-

 

Deposits

 

 

-

 

 

 

(25,949 )

Prepaid expenses

 

 

-

 

 

 

(18,797 )

Accounts payable and accrued expenses

 

 

-

 

 

 

(2,809 )

Total adjustments

 

 

185,945

 

 

 

(61,089 )

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

487,010

 

 

 

1,119,888

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

 

Investment in short term loans

 

 

-

 

 

 

(411,311 )

Net cash provided by investing activities

 

 

-

 

 

 

(411,311 )

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from notes payable

 

 

-

 

 

 

119,032

 

Payments of notes payable

 

 

(138,397 )

 

 

-

 

Net cash provided (used) by financing activities

 

 

(138,397 )

 

 

119,032

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash

 

 

348,613

 

 

 

827,609

 

 

 

 

 

 

 

 

 

 

Cash at beginning of period

 

 

218,388

 

 

 

2,632

 

 

 

 

 

 

 

 

 

 

Cash at end of period

 

$ 567,001

 

 

$ 830,241

 

 

 

 

 

 

 

 

 

 

Supplemental Schedule of Cash Flow Information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ -

 

 

$ -

 

Cash paid for income taxes

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

Supplemental Schedules of Noncash Investing and Financing Activities:

 

 

 

 

 

 

 

 

Preferred B shares issued for acquisition of subsidiaries

 

$ -

 

 

$ 4,000

 

Conversion of debt to common stock

 

$ 2,825

 

 

$ 10,000

 

 

See accompanying notes to the financial statements

 

 
F-5
 
Table of Contents

 

MEDX Holdings, Inc.

Note to the Unaudited Financial Statements for the

Six Months ended June 30 , 2019

 

NOTE 1 - ORGANIZATION AND OPERATIONS

 

MedX Holdings is a Wyoming corporation originally incorporated under on September 5, 2005 in the state of Colorado and was redomiciled to Wyoming effective December 28, 2015. Originally a developmental business, the Company has now become a holding company focused on acquiring businesses throughout the United States with proven track records to maximize the return on investment. Through its subsidiaries, MedX Holdings can acquire real estate, develop, and build residential or commercial properties for long term cash flow or for immediate sale. MedX Holdings will continue expanding its operations to increase its net worth and corporate value.

 

The Company has never been classified as a “Shell” by any governmental agency, and in light of its history and continued growth does not foresee its status changing.

 

The Company is not currently subject to any legal action or in default of any debt covenants.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. On January 15, 2018, the Company acquired MJ Builders of MN, LLC (“MJ”) as the Company’s wholly owned subsidiary. On January 15, 2018, the Company acquired DDG Properties, LLC (“DDG”) as the Company’s wholly owned subsidiary. For purposes of theses financial statements, all financial amounts, including the income, expenses, assets, liabilities, shareholders’ equity/(deficit), cash flows and stock shares, are presented on a consolidated basis as though MJ and DDG were wholly-owned subsidiaries of the Company as of the date indicated including the financial amounts for dates prior to the merger on January 15, 2018.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

For purposes of the statements of cash flows, cash equivalents include all highly liquid investments with original maturities of three months or less which are not securing any corporate obligations. The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.

 

Accounts Receivable

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. Accounts receivable as of June 30 , 201 9 and December 31, 2018 are $69,626 and $48,120 respectively.

 

 
F-6
 
Table of Contents

 

Prepaid Expenses

 

Prepaid expenses consist primarily of short-term prepaid expenditures or contractor deposits that will amortize within one year.

 

Revenue Recognition

 

The Company recognizes Construction and Rental revenues from its interests in the Construction Company and Properties Company, respectively which was produced from Labor, Projects, and Rental Billing when ultimate collection was reasonably assured.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain.

 

The Company also follows the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. No liability for unrecognized tax benefits was recorded as of December 31, 2018 and 2017.

 

Stock-Based Compensation

 

The Company records stock-based compensation at fair value as of the date of grant and recognizes the corresponding expense over the requisite service period (usually the vesting period), utilizing the Black-Scholes option-pricing model. The volatility component of the calculation is based on the historic volatility of the Company’s stock or the expected future volatility. The expected life assumption is primarily based on historical exercise patterns and employee post-vesting termination behavior. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

Net Profit per Common Share

 

Basic earnings per share are calculated by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share are based on the assumption that all dilutive convertible shares and stock options and warrants were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, warrants and options are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

 
F-7
 
Table of Contents

 

Related Party Transactions

 

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to the related party.

 

The Company considers all officers, directors, senior management personnel, and senior level consultants to be related parties to the Company.

 

Derivative Liabilities

 

The Company assessed the classification of its derivative financial instruments as of December 31, 2016, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815.

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

 

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.

 

 
F-8
 
Table of Contents

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

 

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control or could require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Recently Adopted Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 – ASSET RETIREMENT OBLIGATIONS

 

The Company recognizes the present value of obligations associated with the retirement of tangible long- lived assets in the period in which it is incurred. The liability is capitalized as part of the related asset’s carrying amount. Over time, accretion of the liability is recognized as an operating expense and the capitalized cost is depreciated over the expected useful life of the related asset. Currently all rental properties are depreciated on an amortized schedule of 50 years. There is no foreseeable depreciative action that would require the retirement or operating expenses to the business for any of the owned properties.

 

NOTE4 – EQUITY

 

a) Authorized

 

Authorized capital stock consists of:

 

 

·

200,000,000 common shares with a par value of $0.001 per share; and

 

· Preferred shares with a par value of $0.001 per share;

 

The Company has designated 3,000,000 shares as Series A Convertible Preferred Series Stock. Each share of Series A Preferred Stock is convertible into fifty (50) shares of Common Stock.

 

The Company has designated 4,000,000 shares as Series B Convertible Preferred Series Stock. Each share of Series B Preferred Stock is convertible into one (1) share of Common Stock.

 Share issuances

 

On January 15, 2018 the Company issued 4,000,000 Series B Preferred Shares for acquisition purposes at a price of $0.25 per share (see NOTE 5).

 

On April 19, 2018 the Company issued 10,000,000 Common shares to an accredited investor on the conversion of $7,250 of convertible debt at a price of $0.0003 per share.

 

 
F-9
 
Table of Contents

 

On December 4, 2018 the Company issued 11,000,000 Common shares to an accredited investor on the conversion of $7,021 of convertible debt at a price of $0.0003 per share.

 

NOTE 5 – MERGER WITH MJ BUILDERS OF MN, LLC AND DDG PROPERTIES, LLC

 

On January 15 t h , 2018 , the Company acquired MJ Builders of MN, LLC and DDG Properties, LLC as wholly owned subsidiaries of MedX Holdings, Inc., which exchanged 4,000,000 Preferred B Series at $0.25 per share, in exchange for the member interests in the two companies. The Company acquired the following assets and liabilities:

 

Fair Value of Assets Acquired

 

MJ Builders

 

 

DDG Properties

 

Cash

 

$ 130,000.00

 

 

$ 92,378.00

 

Loans receivable

 

 

407,000.00

 

 

 

-

 

Rental properties

 

 

-

 

 

 

234,907.00

 

Prepaids

 

 

-

 

 

 

28,500.00

 

Equipment

 

 

37,500.00

 

 

 

-

 

Balance of profit in contracts in process - net

 

 

75,000.00

 

 

 

-

 

 

 

 

649,500.00

 

 

 

355,785.00

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

5,285.00

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net purchase price

 

$ 644,215.00

 

 

$ 355,785.00

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

$ 1,000,000.00

 

 

NOTE 6 - CONVERTIBLE DEBT

 

At June 30, 2019 and December 31, 2018 convertible notes and debentures consisted of the following:

 

 

 

June 30,
2019

 

 

December 31,
2018

 

Convertible notes payable

 

$ 25,000

 

 

$ 25,000

 

Unamortized debt discount

 

 

(5,554 )

 

 

(22,222 )

Carrying amount

 

$ 19,446

 

 

$ 2,778

 

Less: current portion

 

 

(19,446 )

 

 

(2,778 )

Long-term convertible notes, net

 

$ -

 

 

$ -

 

 

In December 2018, the Company entered into a Convertible Promissory Note. The note is convertible at a discount of seventy five percent (75%) of the market price of the Company s Common Stock determined based on the lowest trading price in a thirty (30) day period prior to the date of conversion

 

The following table summarizes the debt discounts recorded on convertible debt in connection with the above convertible debentures.

 

 

 

June 30,
2019

 

 

December 31,
2018

 

Debt Discount beginning balance

 

$ 22,222

 

 

$ -

 

Additions

 

 

-

 

 

 

25,000

 

Amortization

 

 

(16,668 )

 

 

(2,778 )

Warrant adjustments

 

 

-

 

 

 

-

 

Ending Balance

 

$ 5,554

 

 

$ 22,222

 

 

 
F-10
 
Table of Contents

 

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in the year ended December 31, 2018. These embedded derivatives included certain conversion features as described in the preceding paragraph. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Notes, the Company determined a fair value of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the assumptions outlined in the following tables:

 

 

 

 

 

 

 

Black - Scholes Assumptions

 

 

Derivative

 

 

 

 

 

 

 

 

December 31. 2018

 

 

Liability

 

 

 

  Original

 

 

  Term

 

 

  Full Conv.

 

  Dividend

 

 

 

 

  Risk Free

 

 

 

Date

 

Amount

 

 

  (Months)

 

 

  Y/N

 

Yield

 

 

Volatility

 

 

  Rate

 

 

12/31/18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12/31/2018

 

$ 25,000

 

 

 

9

 

 

N

 

 

0.00 %

 

 

231.4 %

 

 

2.63 %

 

$ 40,533

 

  

 

 

 

 

 

Remaining

 

 

 

 

Black-Scholes Assumptions

 

 

Derivative

 

 

 

  Original

 

 

Term

 

 

Full

 

June 30, 2019

 

 

Liability

 

Date

 

 Amount

 

 

 (Months)

 

 

Conv. Y/N

 

Dividend Yield

 

 

Volatility

 

 

Risk Free Rate

 

 

06/30/18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

06/30/2019

 

$ 25,000

 

 

 

2

 

 

N

 

 

0.00 %

 

 

246.91 %

 

 

2.15 %

 

$ 15,882

 

 

NOTE 7 NOTES PAYABLE

 

At June 30, 2019 and 2018, term notes consisted of the following:

 

 

 

June 30,
2019

 

 

December 31,
2018

 

Mortgage note #1

 

$ 174

 

 

$ 21,374

 

Mortgage note #2

 

 

72,868

 

 

 

117,400

 

Mortgage note #3

 

 

60,000

 

 

 

132,665

 

Term note

 

 

2,825

 

 

 

-

 

Total Notes

 

$ 135,867

 

 

$ 271,439

 

 

NOTE 8 FAIR VALUE OF FINANCIAL INSTRUMENTS

 

ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

 

 

  
F-11
 
Table of Contents

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of June 30 , 2019 and December 31, 2018:

 

 

 

 

Fair Value Measurements at June 30, 2019 using:

 

 

 

March 31,

2019

 

 

Quoted Prices
in Active
Markets for Identical
Assets (Level 1)

 

 

Significant
Other
Observable
Inputs (Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Liabilities

 

$ 15,882

 

 

 

-

 

 

 

-

 

 

$ 15,882

 

 

 

 

 

 

Fair Value Measurements at December 31, 2018 using:

 

 

 

December 31,

2018

 

 

Quoted Prices

in Active

Markets for Identical

Assets (Level 1)

 

 

Significant

Other

Observable

Inputs (Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Liabilities

 

$ 40,533

 

 

 

-

 

 

 

-

 

 

$ 40,533

 

 

The debt and warrant derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors based on historical prices for the Company s common stock and are classified within Level 3 of the valuation hierarchy.

 

The following table provides a summary of changes in fair value of the Company s Level 3 financial liabilities as of June 30 , 201 9 :

 

 

 

Derivative

Liability

 

Balance, December 31, 2018

 

$ (40,533 )

Additions

 

 

-

 

Change in fair value of derivative liabilities

 

 

24,671

 

Balance, June 30, 2019

 

$ (15,882 )
 

NOTE 9 SUBSEQUENT EVENTS

 

The Company management has evaluated events occurring subsequent to June 30 , 2019 through August 30, 2019 , the following material subsequent events have taken place.

 

In August 8, 2019, Mark Miller, CEO and sole Director of MEDH acquired an Intellectual Property asset known as Tumbleweed from a Mr. Black in exchange for the transfer of 5,000,000 restricted Common Shares of MedX Holdings, Inc. which Mr. Miller personally owned.

 

As such effective with that date, Mr. Millers holdings of Common shares of the Company were reduced from 98,117,200 common shares to 93,117,200 common shares.

 

On June 2, 2019, the Company entered into a conversion and settlement agreement with the holder of a Promissory Note. Under terms of the agreement, the first issuance of shares 13,300,000 commons shares, settled one third of the open balance of the note. The remaining shares and balances will be settled in coming months.

 

In July 2019, Mark Miller, CEO surrendered back to the Company for cancellation 295,000 Common shares. The shares were returned without remuneration, and effectively reduced the issued and outstanding shares of the Company at that time.

 

  
F-12
 
Table of Contents

                  

Unaudited Balance Sheets at December 31, 2018 and 2017

F-14

  

 

Unaudited Statements of Operations for the years ended December 31, 2018 and 2017

F-15

  

 

Unaudited Statements of Stockholders Deficit for the years ending December 31, 2018 and 2018

F-16

  

 

Unaudited Consolidated Statements of Cash Flows for the years ended December 31, 2018 and 2017

F-17

  

 

Notes to the Unaudited Consolidated Financial Statements

F-18 to F-24

 
 
F-13
 
Table of Contents

 

MEDEX Holdings, Inc.

BALANCE SHEETS

(Unaudited)

 

 

 

December 31,

2018

 

 

December 31,

2017

 

 

 

 

 

 

 

 

ASSETS

Current assets:

 

 

 

 

 

 

Cash

 

$ 218,388

 

 

$ 11,312

 

Deposits on orders

 

 

-

 

 

 

10,942

 

Accounts receivable (net of reserve for bad debts of $0 and $0, respectively)

 

 

48,120

 

 

 

26,076

 

Loans receivable (net of reserve for bad debts of $450,000 and $0, respectively)

 

 

744,223

 

 

 

-

 

Prepaid expenses - current

 

 

28,550

 

 

 

9,753

 

Total current assets

 

 

1,039,281

 

 

 

58,083

 

Fixed and intangible assets:

 

 

 

 

 

 

 

 

Capital assets

 

 

146,000

 

 

 

146,000

 

Rental properties

 

 

230,209

 

 

 

234,907

 

Equipment

 

 

30,000

 

 

 

37,500

 

Intangible assets

 

 

200

 

 

 

200

 

Fixed and intangible assets, net

 

 

406,409

 

 

 

418,607

 

Other assets:

 

 

 

 

 

 

 

 

Investment in subsidiaries

 

 

1,000,000

 

 

 

-

 

Capitalized Re-Organization costs

 

 

13,000

 

 

 

13,000

 

Total other assets

 

 

1,013,000

 

 

 

13,000

 

Total assets

 

$ 2,458,690

 

 

$ 489,690

 

 

LIABILITIES AND STOCKHOLDERS DEFICIT

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$ 3,219

 

 

$ 10,483

 

Notes payable

 

 

271,439

 

 

 

235,041

 

Convertible promissory notes (net of debt discount of $22,222 and $0, respectively)

 

 

2,778

 

 

 

12,241

 

Derivative instrument liability

 

 

40,532

 

 

 

-

 

Total current liabilities

 

 

317,968

 

 

 

257,765

 

Total long-term liabilities

 

 

-

 

 

 

-

 

Total liabilities

 

 

317,968

 

 

 

257,765

 

Commitments and contingencies

 

 

-

 

 

 

-

 

Stockholders’ deficit

 

 

 

 

 

 

 

 

Preferred stock Series A - $0.001 par value, authorized - 3,000,000 shares; issued and outstanding 400,000 and 400,000 respectively 400 400

 

 

 

 

 

 

 

 

Preferred stock Series B - $0.001 par value, authorized - 4,000,000 shares; 4,000,000 and -0- shares issued and outstanding, respectively

 

 

4,000

 

 

 

-

 

Common Stock - $0.001 par value; 200,000,000 shares authorize; issued and outstanding 133,611,216 and 112,611,216 shares, respectively

 

 

133,611

 

 

 

112,611

 

Additional paid-in capital

 

 

1,601,011

 

 

 

611,170

 

Accumulated retained earnings

 

 

401,700

 

 

 

(494,856 )

Total stockholders' deficit

 

 

2,140,722

 

 

 

229,325

 

Total liabilities and stockholders' deficit

 

$ 2,458,690

 

 

$ 487,090

 

 

See accompanying notes to the financial statements

 

 
F-14
 
Table of Contents

 

MEDX Holdings, Inc.

STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

For the years ended

 

 

 

December 31,

2018

 

 

December 31,

2017

 

 

 

 

 

 

 

 

 

 

Rental income

 

$ 886,758

 

 

$ 51,947

 

Project income

 

 

1,289,170

 

 

 

672,876

 

Total Revenues

 

 

2,175,928

 

 

 

724,823

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

525,077

 

 

 

235,555

 

Insurance

 

 

11,756

 

 

 

4,341

 

Depreciation

 

 

12,198

 

 

 

-

 

Cost of sales

 

 

549,031

 

 

 

239,896

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

1,626,897

 

 

 

484,926

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

General and administrative

 

 

711,807

 

 

 

57,087

 

Total operating expenses

 

 

711,807

 

 

 

57,087

 

 

 

 

 

 

 

 

 

 

Profit from operations

 

 

915,090

 

 

 

427,839

 

 

 

 

 

 

 

 

 

 

Other Income / (Expense):

 

 

 

 

 

 

 

 

Interest expense

 

 

(225 )

 

 

(1,780 )

Loss on change in value of derivative liability

 

 

(15,532 )

 

 

-

 

Amortization of debt discount

 

 

(2,778 )

 

 

-

 

Total other income / (expense)

 

 

(18,535 )

 

 

(1,780 )

 

 

 

 

 

 

 

 

 

Net profit (loss) applicable to common stock holders

 

$ 896,555

 

 

$ 426,059

 

 

 

 

 

 

 

 

 

 

Per share data

 

 

 

 

 

 

 

 

Net Profit per share - basic and diluted

 

$ 0.01

 

 

$ 0.00

 

Weighted average number of shares outstanding- basic and diluted

 

 

115,981,179

 

 

 

112,611,216

 

 

See accompanying notes to the financial statements

 

 
F-15
 
Table of Contents

 

MEDX Holdings, Inc.

STATEMENTS OF STOCKHOLDERS' DEFICIT

(Unaudited)

 

 

 

Preferred A Series Stock

($0.001 par value)

 

 

Preferred B Series Stock

($0.001 par value)

 

 

Common Stock

($.001 par value)

 

 

Additional Paid-In

 

 

Accumulated

 

 

Total Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2017

 

$ 400,000

 

 

$ 400

 

 

 

-

 

 

$ -

 

 

 

41,724,016

 

 

$ 41,724

 

 

$ 1,038,629

 

 

$ (1,122,177 )

 

$ (41,424 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

72,917,200

 

 

 

72,917

 

 

 

(72,917 )

 

 

41,754

 

 

 

41,754

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Correcting adj. – O/S Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,030,000 )

 

 

(2,030 )

 

 

-

 

 

 

 

 

 

 

(2,030 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Correcting adj. - equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(353,972 )

 

 

438,939

 

 

 

84,967

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

146,628

 

 

 

146,628

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2017

 

 

400,000

 

 

 

400

 

 

 

-

 

 

 

-

 

 

 

112,611,216

 

 

 

112,611

 

 

 

611,170

 

 

 

(494,856 )

 

 

229,895

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion of debentures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21,000,000

 

 

 

21,000

 

 

 

(6,729 )

 

 

 

 

 

 

14,271

 

Correction – rounding error

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

Acquisition of MJ Builders of MN & DDG Properties, LLC

 

 

 

 

 

 

 

 

 

 

4,000,000

 

 

 

4,000

 

 

 

 

 

 

 

 

 

 

 

996,000

 

 

 

 

 

 

 

1,000,000

 

Net Income (Loss)

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

896,555

 

 

 

896,555

 

Balance, December 31, 2018

 

 

400,000

 

 

$ 400

 

 

 

4,000,000

 

 

$ 4,000

 

 

 

133,611,216

 

 

$ 133,611

 

 

$ 1,601,011

 

 

$ 401,700

 

 

$ 2,140,722

 

 

See accompanying notes to the financial statements

 

 
F-16
 
Table of Contents

 

MEDX Holdings, Inc.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

For the years ended

 

 

 

December 31,

2018

 

 

December 31,

2017

 

Cash flows from operating activities:

 

 

 

 

 

 

Net profit (loss)

 

$ 896,555

 

 

$ 146,628

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

12,198

 

 

 

-

 

Preferred stock issued for services

 

 

14,271

 

 

 

-

 

Amortization of debt discount

 

 

2,778

 

 

 

-

 

Change in fair value of derivative liability

 

 

15,532

 

 

 

-

 

Changes in operating asset and liability account balances:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(22,044 )

 

 

(26,076 )

Deposits

 

 

10,942

 

 

 

(10,942 )

Prepaid expenses

 

 

(18,797 )

 

 

(9,753 )

Accounts payable and accrued expenses

 

 

(21,634 )

 

 

10,483

 

Total adjustments

 

 

(6,754 )

 

 

(36,288 )

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

889,801

 

 

 

110,340

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

 

Property purchases

 

 

-

 

 

 

(234,907 )

Purchase of equipment

 

 

-

 

 

 

(37,500 )

Investment in short term loans

 

 

(744,223 )

 

 

-

 

Net cash used in investing activities

 

 

(744,223 )

 

 

(272,407 )

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from notes payable

 

 

36,498

 

 

 

173,379

 

Proceeds from convertible notes

 

 

25,000

 

 

 

-

 

Net cash provided by financing activities

 

 

61,498

 

 

 

173,379

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash

 

 

207,076

 

 

 

11,312

 

 

 

 

 

 

 

 

 

 

Cash at beginning of period

 

 

11,312

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash at end of period

 

$ 218,388

 

 

$ 11,312

 

 

 

 

 

 

 

 

 

 

Supplemental Schedule of Cash Flow Information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ -

 

 

$ -

 

Cash paid for income taxes

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

Supplemental Schedules of Noncash Investing and Financing Activities:

 

 

 

 

 

 

 

 

Preferred A shares issued for acquisition of subsidiaries

 

$ -

 

 

$ 2,600

 

Common stock issued for services

 

$ 4,000

 

 

$ -

 

Conversion of debt to common stock

 

$ 14,271

 

 

$ 72,917

 

 

See accompanying notes to the financial statements

 

 
F-17
 
Table of Contents

 

MEDX Holdings, Inc.

Note to the Unaudited Financial Statements for the Year ended December 31, 2018

 

NOTE 1 ‐ ORGANIZATION AND OPERATIONS

 

MedX Holdings is a Wyoming corporation originally incorporated under on September 5, 2005 in the state of Colorado, and was redomiciled to Wyoming effective December 28, 2015. Originally a developmental business, the Company has now become a holding company focused on acquiring businesses throughout the United States with proven track records to maximize the return on investment. Through its subsidiaries, MedX Holdings can acquire real estate, develop, and build residential or commercial properties for long term cash flow or for immediate sale. MedX Holdings will continue expanding its operations to increase its net worth and corporate value.

 

The Company has never been classified as a “Shell” by any governmental agency, and in light of its history and continued growth does not foresee its status changing.

 

The Company is not currently subject to any legal action or in default of any debt covenants.

 

NOTE 2 ‐ SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. On January 15, 2018, the Company acquired MJ Builders of MN, LLC (“MJ”) as the Company’s wholly-owned subsidiary. On January 15, 2018, the Company acquired DDG Properties, LLC (“DDG”) as the Company’s wholly-owned subsidiary. For purposes of theses financial statements, all financial amounts, including the income, expenses, assets, liabilities, shareholders’ equity/(deficit), cash flows and stock shares, are presented on a consolidated basis as though MJ and DDG were wholly-owned subsidiaries of the Company as of the date indicated including the financial amounts for dates prior to the merger on January 15, 2018.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

For purposes of the statements of cash flows, cash equivalents include all highly liquid investments with original maturities of three months or less which are not securing any corporate obligations. The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.

 

Accounts Receivable

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. Accounts receivable as of December 31, 2018 and 2017 are $48,120 and $26,076 respectively.

 

 
F-18
 
Table of Contents

 

Prepaid Expenses

 

Prepaid expenses consist primarily of short-term prepaid expenditures or contractor deposits that will amortize within one year.

 

Revenue Recognition

 

The Company recognizes Construction and Rental revenues from its interests in the Construction Company and Properties Company, respectively which was produced from Labor, Projects, and Rental Billing when ultimate collection was reasonably assured.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain.

 

The Company also follows the guidance related to accounting for income tax uncertainties. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. No liability for unrecognized tax benefits was recorded as of December 31, 2018 and 2017.

 

Stock-Based Compensation

 

The Company records stock-based compensation at fair value as of the date of grant and recognizes the corresponding expense over the requisite service period (usually the vesting period), utilizing the Black- Scholes option-pricing model. The volatility component of the calculation is based on the historic volatility of the Company’s stock or the expected future volatility. The expected life assumption is primarily based on historical exercise patterns and employee post-vesting termination behavior. The risk- free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

Net Profit per Common Share

 

Basic earnings per share are calculated by dividing income available to common stockholders by the weighted average number of common shares outstanding. Diluted earnings per share are based on the assumption that all dilutive convertible shares and stock options and warrants were converted or exercised. Dilution is computed by applying the treasury stock method. Under this method, warrants and options are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period.

 

 
F-19
 
Table of Contents

 

Related Party Transactions

 

Parties are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a distribution to the related party.

 

The Company considers all officers, directors, senior management personnel, and senior level consultants to be related parties to the Company.

 

Derivative Liabilities

 

The Company assessed the classification of its derivative financial instruments as of December 31, 2016, which consist of convertible instruments and rights to shares of the Company’s common stock and determined that such derivatives meet the criteria for liability classification under ASC 815.

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

o) Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with professional standards for “Accounting for Derivative Instruments and Hedging Activities”.

 

Professional standards generally provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of “Conventional Convertible Debt Instrument”.

 

 
F-20
 
Table of Contents

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

 

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control or could require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Recently Adopted Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

NOTE 3 – ASSET RETIREMENT OBLIGATIONS

 

The Company recognizes the present value of obligations associated with the retirement of tangible long- lived assets in the period in which it is incurred. The liability is capitalized as part of the related asset’s carrying amount. Over time, accretion of the liability is recognized as an operating expense and the capitalized cost is depreciated over the expected useful life of the related asset. Currently all rental properties are depreciated on an amortized schedule of 50 years. There is no foreseeable depreciative action that would require the retirement or operating expenses to the business for any of the owned properties.

 

NOTE4 – EQUITY

 

a) Authorized

 

Authorized capital stock consists of:

 

 

· 200,000,000 common shares with a par value of $0.001 per share; and

 

· Preferred shares with a par value of $0.001 per share;

 

· The Company has designated 3,000,000 shares as Series A Convertible Preferred Series Stock. Each share of Series A Preferred Stock is convertible into fifty (50) shares of Common Stock.

 

· The Company has designated 4,000,000 shares as Series B Convertible Preferred Series Stock. Each share of Series B Preferred Stock is convertible into one (1) share of Common Stock.

 

Share issuances

 

On January 25, 2018 the Company issued 4,000,000 Series B Preferred Shares for acquisition purposes at a price of $0.25 per share (see NOTE 5).

 

On April 19, 2018 the Company issued 10,000,000 Common shares to an accredited investor on the conversion of $7,250 of convertible debt at a price of $0.0003 per share.

 

 
F-21
 
Table of Contents

 

On December 4, 2018 the Company issued 11,000,000 Common shares to an accredited investor on the conversion of $7,021 of convertible debt at a price of $0.0003 per share.

 

NOTE 5 – MERGER WITH MJ BUILDERS OF MN, LLC AND DDG PROPERTIES, LLC

 

On January 15th, 2018, the Company acquired MJ Builders of MN, LLC and DDG Properties, LLC as wholly owned subsidiaries of MedX Holdings, Inc., which exchanged 4,000,000 Preferred B Series Shares for the Companies. The State of Wyoming has recognized the issuance of these shares.

 

NOTE 6 ‐ CONVERTIBLE DEBT

 

At December 31, 2018 and 2017 convertible notes and debentures consisted of the following:

 

 

 

December 31,

2018

 

 

December 31,

2017

 

Convertible notes payable

 

$ 25,000

 

 

$ -

 

Unamortized debt discount

 

 

(22,222 )

 

 

-

 

Carrying amount

 

$ 2,778

 

 

$ -

 

Less: current portion

 

 

(2,778 )

 

 

-

 

Long‐term convertible notes, net

 

$ -

 

 

$ -

 

 

In December 2018, the Company entered into a Convertible Promissory Note. The note is convertible at a discount of seventy five percent (75%) of the market price of the Company’s Common Stock determined based on the lowest trading price in a thirty (30) day period prior to the date of conversion

 

The following table summarizes the debt discounts recorded on convertible debt in connection with the above convertible debentures.

 

 

 

December 31,

2018

 

 

December 31,

2017

 

Debt Discount beginning balance

 

$ -

 

 

$ ‐

 

Additions

 

 

25,000

 

 

 

-

 

Amortization

 

 

(2,778 )

 

 

-

 

Warrant adjustments

 

 

-

 

 

 

-

 

Ending Balance

 

$ 22,222

 

 

$ -

 

 

The Company identified embedded derivatives related to the Convertible Promissory Notes entered into in the years ended December 31, 2018 and 2017. These embedded derivatives included certain conversion features as described in the preceding paragraph. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Notes, the Company determined a fair value of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model based on the assumptions outlined in the following table:

 

Black-Scholes Assumptions

Derivative

December 31. 2018

Liability

Original

Term

Full Conv.

Dividend

Risk Free

Date

Amount

(Months)

Y/N

Yield

Volatility

Rate

12/31/18

12/3/2018

$ 25,000 9

N

0.00 % 231.4 % 2.63 % $ 40,532

 

 
F-22
 
Table of Contents

 

NOTE 7 – FAIR VALUE OF FINANCIAL INSTRUMENTS

 

ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2018:

 

 

 

 

 

Fair Value Measurements at December 31, 2016 using:

 

 

 

December 31,

2018

 

 

Quoted Prices in Active Markets for Identical

Assets (Level 1)

 

 

Significant Other Observable

Inputs (Level 2)

 

 

Significant Unobservable Inputs

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Liabilities

 

$ 40,532

 

 

 

-

 

 

 

-

 

 

$ 40,532

 

 

Fair Value Measurements at December 31, 2015 using:

December 31,

2017

Quoted Prices in Active Markets for Identical

Assets (Level 1)

Significant

Other

Observable

Inputs (Level 2)

Significant Unobservable

Inputs

(Level 3)

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Liabilities

$ - - - $ -

 

The debt and warrant derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors based on historical prices for the Company’s common stock and are classified within Level 3 of the valuation hierarchy.

 

  
F-23
 
Table of Contents

 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2018:

 

 

 

Derivative

Liability

 

Balance, December 31, 2017

 

$ -

 

Additions

 

 

(33,032 )

Change in fair value of derivative liabilities

 

 

(7,500 )

Balance, December 31, 2018

 

$ (40,532 )

 

NOTE 8 – PROPERTY VALUATION

 

On March 22, 2018 a private CMA was paid for by the company to appraise the current asset value of the Single Family Residences, Commercial Properties, and Raw Land owned by the wholly owned subsidiary DDG Properties, LLC. which confirmed a $6.7 Million USD Valuation. The appraisal cost was $2,500, this expense was acknowledged under COGS in the financial statements and was paid in full at the time of completion.

 

NOTE 9 – SUBSEQUENT EVENTS

 

The Company management has evaluated events occurring subsequent to December 31, 2018 through the date that these consolidated financial statements were issued, and there are no material subsequent events that have taken place.

 

 
F-24

 

  EXHIBIT 2.1

 

 

 

 

 
 
 

 

 

 
 
 

 

 

 
 

 

  EXHIBIT 2.2

 

 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 

 

  EXHIBIT 2.3

 

 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 

 

  EXHIBIT 2.4

 

 

 

 

 
 
 

 

 

 
 

 

  EXHIBIT 2.5

 

 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 
 

 

 

 
 

 

EXHIBIT 2.6

 

BYLAWS

OF

MEDX HOLDINGS, INC.

 

ARTICLE I

OFFICES

 

Section 1.1 Principal Office. The principal office of the corporation shall be located as designated by the Board of Directors, either within or without the State of Wyoming. The corporation may have such other offices, either within or without the State of Wyoming, as the Board of Directors may designate or as the business of the corporation may require from time to time.

 

Section 1.2 Registered Office. The registered office of the corporation, required by the Wyoming Business Corporation Act to be maintained in the State of Wyoming, may be, but need not be, identical with the principal office if located in the State of Wyoming, and the address of the registered office may be changed from time to time by the Board of Directors.

 

ARTICLE II

SHAREHOLDERS

 

Section 2.1 Annual Meeting. The annual meeting of the shareholders shall be held at such time on such day as shall be fixed by the Board of Directors, for the purpose of electing directors and for the transacting of such other business as may come before the meeting. If the election of directors shall not be held on the date designated herein for any annual meeting of the shareholders, or at any adjournment thereof, the Board of Directors shall cause the election to be held at a special meeting of the shareholders as soon thereafter as may be convenient.

 

Section 2.2 Special Meetings. Special meetings of the shareholders, for any purpose or purposes, unless otherwise prescribed by statute, may be called by the President or by the Board of Directors, and shall be called by the President at the request of the holders of not less than one-tenth of all votes entitled to be cast at the meeting; provided, however, that the requesting holders must have held their ownership in the corporation for at least twelve consecutive months.

 

Section 2.3 Place of Meetings. The Board of Directors may designate any place, either within or without the State of Wyoming, as the place of meeting for any annual meeting or for any special meeting called by the Board of Directors. A waiver of notice signed by all shareholders entitled to vote at a meeting may designate any place, either within or without the State of Wyoming, as the place for the holding of such meeting. If no designation is made, or if a special meeting be otherwise called, the place of meeting shall be the principal office of the corporation in the State of Wyoming.

 

Section 2.4 Notice of Meeting. Written notice stating the place, day and hour of the meeting of shareholders and, in case of a special meeting, the purpose or purposes for which the meeting is called, shall, unless otherwise prescribed by statute, be delivered not less than ten nor more than 50 days before the date of the meeting, either personally or by mail, by or at the direction of the President, or the Secretary, or the officer or other persons calling the meeting, to each shareholder of record entitled to vote at such meeting; provided, however, that if the authorized shares of the corporation are to be increased, at least 30 days’ notice shall be given. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at his address as it appears on the stock transfer books of the corporation, with postage thereon prepaid.

 

 
1
 
 

  

Section 2.5 Meeting of all Shareholders. If all of the shareholders shall meet at any time and place, either within or without the State of Wyoming, and consent to the holding of a meeting at such time and place, such meeting shall be valid without call or notice, and at such meeting any corporate action may be taken.

 

Section 2.6 Fixing of Record Date. The Board of Directors may fix in advance a date as the record date for any such determination of shareholders, such date in any case to be not more than 50 days and, in case of a meeting of shareholders, not less than ten days prior to the date on which the particular action, requiring such determination of shareholders, is to be taken. If no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of shareholders. When a determination of shareholders entitled to vote at any meeting of shareholders has been made as provided in this section, such determination shall apply to any adjournment thereof.

 

Section 2.7 Voting Record. The officer or agent having charge of the stock transfer books for shares of the corporation shall make, at least ten days before such meeting of shareholders, a complete record of the shareholders entitled to vote at each meeting of shareholders or any adjournment thereof, arranged in alphabetical order, with the address of and the number of shares held by each. The record, for a period of ten days prior to such meeting, shall be kept on file at the principal office of the corporation, whether within or without the State of Wyoming, and shall be subject to inspection by any shareholder for any purpose germane to the meeting at any time during usual business hours. Such record shall be produced and kept open at the time and place of the meeting and shall be subject to the inspection of any shareholder during the whole time of the meeting for the purposes thereof.

 

The original stock transfer books shall be the prima facie evidence as to the identity of the shareholders entitled to examine the record or transfer books or to vote at any meeting of shareholders.

 

Section 2.8 Quorum. One-third of the outstanding shares of the corporation entitled to vote, represented in person or by proxy, shall constitute a quorum at any meeting of shareholders, except as otherwise provided by the Wyoming Business Corporation Act and the Articles of Incorporation. In the absence of a quorum at any such meeting, a majority of the shares so represented may adjourn the meeting from time to time for a period not to exceed 60 days. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted which might have been transacted at the original meeting as originally noticed. The shareholders present at a duly organized meeting may continue to transact business until adjournment, notwithstanding the withdrawal of enough shareholders to leave less than a quorum.

 

 
2
 
 

 

Section 2.9 Manner of Acting. If a quorum is present, the affirmative vote of the majority of the votes cast on any matter submitted for shareholder action shall be the act of the shareholders, unless the vote of a greater proportion or number or voting by classes is otherwise required by statute or by the Articles of Incorporation or these Bylaws.

 

Section 2.10 Proxies. At all meetings of shareholders a shareholder may vote in person or by proxy executed in writing by the shareholder or by his duly authorized attorney-in-fact. Such proxy shall be filed with the Secretary of the corporation before or at the time of the meeting. No proxy shall be valid after 11 months from the date of its execution, unless otherwise provided in the proxy. Proxies shall be in such form as shall be required by the Board and as set forth in the notice of meeting and/or proxy or information statement concerning such meeting.

 

Section 2.11 Voting of Shares. Unless otherwise provided by these Bylaws or the Articles of Incorporation, each outstanding share entitled to vote shall be entitled to one vote upon each matter submitted to a vote at a meeting of shareholders, and each fractional share shall be entitled to a corresponding fractional vote on each such matter.

 

Section 2.12 Voting of Shares by Certain Shareholders. Shares standing in the name of another corporation may be voted by such officer, agent or proxy as the bylaws of such corporation may prescribe, or, in the absence of such provision, as the Board of Directors of such other corporation may determine.

 

Shares standing in the name of a deceased person, a minor ward or an incompetent person, may be voted by his administrator, executor, court appointed guardian or conservator, either in person or by proxy without a transfer of such shares into the name of such administrator, executor, court appointed guardian or conservator. Shares standing in the name of a trustee may be voted by him, either in person or by proxy, but no trustee shall be entitled to vote shares held by him without a transfer of such shares into his name.

 

Shares standing in the name of a receiver may be voted by such receiver and shares held by or under the control of a receiver may be voted by such receiver without the transfer thereof into his name if authority so to do is contained in an appropriate order of the court by which the receiver was appointed.

 

A shareholder whose shares are pledged shall be entitled to vote such shares until the shares have been transferred into the name of the pledgee, and thereafter the pledgee shall be entitled to vote the shares so transferred.

 

Neither treasury shares of its own stock belonging to this corporation, nor shares of its own stock held by it in a fiduciary capacity, nor shares of its own stock held by another corporation if the majority of the shares entitled to vote for the election of directors of such other corporation is held by the corporation, may be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number of outstanding shares at any given time.

 

 
3
 
 

 

Redeemable shares which have been called for redemption shall not be entitled to vote on any matter and shall not be deemed outstanding shares on and after the date on which written notice of redemption has been mailed to shareholders and a sum sufficient to redeem such shares has been deposited with a hank or trust company with irrevocable instruction and authority to pay the redemption price to the holders of the shares upon surrender of certificates therefor.

 

Shares held of record by a shareholder but which are held for the account of a specified person or persons may be voted by such person or persons, provided the shareholder has certified to the corporation in writing that all or a portion of the shares registered in the name of the shareholder are held for the account of such person or persons, as provided in Article VI. Section 6.6 of these Bylaws.

 

Section 2.13 Informal Action by Shareholders. Any action required or permitted to be taken at a meeting of the shareholders may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the shareholders entitled to vote with respect to the subject matter thereof. Signature by facsimile shall be given the same force and effect as original signatures, and any consent in writing may be executed in counterparts.

 

Section 2.14 Voting by Ballot. Voting on any question or in any election may be by voice vote unless the presiding officer shall order or any shareholder shall demand that voting be by ballot.

 

Section 2.15 No Cumulative Voting. No shareholder shall be permitted to cumulate his votes by giving one candidate as many votes as the number of such directors multiplied by the number of his shares shall equal, or by distributing such votes on the same principle among any number of candidates.

 

ARTICLE III
BOARD OF DIRECTORS

 

Section 3.1 General Powers. The business and affairs of the corporation shall be managed by its Board of Directors.

 

Section 3.2 Number, Tenure and Qualifications. The initial number of directors shall be four. The number of directors fixed by these bylaws may be increased or decreased from time to time by resolution of the board of directors. The tenure of a director shall not be affected by any decrease or increase in the number of directors so made by the board. Each director shall hold office until the next annual meeting of shareholders and until his successor shall have been elected and qualified.

 

Section 3.3 Regular Meetings. A regular meeting of the Board of Directors shall be held without other notice than this bylaw immediately after, and at the same place as, the annual meeting of shareholders. The Board of Directors may provide, by resolution, the time and place, either within or without the State of Wyoming, for the holding of additional regular meetings, without other notice than such resolution.

 

 
4
 
 

 

Section 3.4 Special Meetings. Special meetings of the Board of Directors may be called by or at the request of the Chairman, if there be one, the President, any of the directors, or by such persons as are authorized to call special meetings under the Wyoming Business Corporation Act. The person or persons authorized to call special meetings of the Board of Directors may fix any place, either within or without the State of Wyoming, as the place for holding any special meeting of the Board of Directors called by them.

 

Section 3.5 Notice. Written notice of any special meeting of directors shall be given by mail to each director at his business address at least three days prior to the meeting or by personal delivery, fax or telegram at least 24 hours prior to the meeting to the business address of each director, or in the event such notice is given on a Saturday, Sunday or holiday, to the residence address of each director, or on such shorter notice as the person or persons calling the meeting, acting in good faith, may deem necessary or appropriate in the circumstances. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, so addressed, with postage thereon prepaid. If notice is given by fax, such notice shall be deemed to be delivered when confirmation (either by electronic means or by the person receiving the fax) of such fax is received by the sender. If notice be given by telegram, such notice shall be deemed to be delivered when the telegram is delivered to the telegraph company.

 

Any director may waive notice of any meeting. The attendance of a director at any meeting shall constitute a waiver of notice of such meeting, except where a director attends a meeting for the express purpose of objecting to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the Board of Directors need be specified in the notice or waiver of notice of such meeting.

 

Section 3.6 Quorum. A majority of the directors shall constitute a quorum for the transaction of business at any meeting of the Board of Directors.

 

Section 3.7 Manner of Acting. Except as otherwise required by law or by the Articles of Incorporation, the act of the majority of the directors present at a meeting at which a quorum is present shall be an act of the Board of Directors.

 

Section 3.8 Action by Directors Without a Meeting. Any action required or permitted to be taken by the Board or Directors or by a committee thereof at a meeting may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the directors or all or the committee members entitled to vote with respect to the subject matter thereof. Signatures may be original signatures or by fax. Signatures on such consent may be made in counterparts.

 

Section 3.9 Participation by Electronic Means. Any members of the Board of Directors or any committee designated by such Board may participate in a meeting of the Board of Directors or committee by means of telephone conference or similar communications equipment by which all persons participating in the meeting can hear each other at the same time. Such participation shall constitute presence in person at the meeting.

 

 
5
 
 

 

Section 3.10 Vacancies. Any vacancy occurring in the Board of Directors may be filled by the affirmative vote of a majority of the remaining directors, though less than a quorum of the Board of Directors. A director elected to fill a vacancy shall be elected for the unexpired term of his predecessor in office. Any directorship to be filled by reason of an increase in the number of directors may be filled by election by the Board of Directors for a term of office continuing only until the next election of directors by the shareholders.

 

Section 3.11 Resignation. Any director of the corporation may resign at any time by giving written notice to the President or the Secretary of the corporation. The resignation of any director shall take effect upon receipt of notice thereof or at any such later time as shall be specified in such notice; and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective. When one or more directors shall resign from the Board, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective.

 

Section 3.12 Removal. Any director or directors of the corporation may be removed at any time, with or without cause, in the manner provided in the Wyoming Business Corporation Act.

 

Section 3.13 Committees. By resolution adopted by a majority of the Board of Directors, the directors may designate two or more directors to constitute a committee, any of which shall have such authority in the management of the corporation as the Board of Directors shall designate and as shall not be proscribed by the Wyoming Business Corporation Act.

 

Section 3.14 Compensation. By resolution of the Board of Directors and irrespective of any personal interest of any of the members, each director may be paid his expenses, if any, of attendance at each meeting of the Board of Directors, and may be paid a stated salary as director or a fixed sum for attendance at each meeting of the Board of Directors, or both. No such payment shall preclude any director from serving the corporation in any other capacity and receiving compensation therefor.

 

Section 3.15 Presumption of Assent. A director of the corporation who is present at a meeting of the Board of Directors at which action on any corporate matter is taken shall be presumed to have assented to the action taken unless the dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent to such action with the person acting as the Secretary of the meeting before the adjournment thereof or shall forward such dissent by registered mail to the Secretary of the corporation immediately after the adjournment of the meeting. Such right to dissent shall not apply to a director who voted in favor of such action.

 

ARTICLE IV
OFFICERS

 

Section 4.1 Number. The officers of the corporation shall be a President, who shall be elected by the Board of Directors. Such other officers and assistant officers as may be deemed necessary may be elected or appointed by the Board of Directors. Any two or more offices may be held by the same person.

 

 
6
 
 

 

Section 4.2 Election and Term of Office. The officers of the corporation to be elected by the Board of Directors shall be elected annually by the Board of Directors at the first meeting of the Board of Directors held after the annual meeting of the shareholders. If the election of officers shall not be held at such meeting, such election shall be held as soon thereafter as practicable. Each officer shall hold office until his successor shall have been duly elected and shall have qualified or until his death or until he shall resign or shall have been removed in the manner hereinafter provided.

 

Section 4.3 Removal. Any officer or agent may be removed by the Board of Directors whenever in its judgment the best interests of the corporation will be served thereby, but such removal shall be without prejudice to the contract rights, if any, of the person so removed. Election or appointment of an officer or agent shall not of itself create contract rights.

 

Section 4.4 Vacancies. A vacancy in any office because of death, resignation, removal, disqualification or otherwise, may be filled by the Board of Directors for the unexpired portion of the term.

 

Section 4.5 Chairman of the Board. If the directors so desire, they may elect a Chairman of the Board from among themselves. The chairman of the board shall preside at all meetings of the stockholders and of the Board of Directors. He shall have such other powers and duties as may be prescribed by the Board of Directors.

 

Section 4.6 President. The President shall be the chief executive officer of the corporation and, subject to the control of the Board of Directors, shall in general supervise and control all of the business and affairs of the corporation. He shall, if no Chairman be elected, be the chief executive officer of the corporation and shall preside at all meetings of the shareholders and of the Board of Directors. He may sign, with the Secretary or any other proper officer of the corporation thereunto authorized by the Board of Directors, certificates for shares of the corporation and deeds, mortgages, bonds, contracts or equipment leases entered into in the ordinary course of business, and other contracts or instruments which the Board of Directors has authorized to be executed, except in cases where the signing and execution thereof shall be expressly delegated by the Board of Directors or by these Bylaws to some other officer or agent of the corporation, or shall be required by law to be otherwise signed or executed; and in general shall perform all duties incident to the office of President and such other duties as may be prescribed by the Board of Directors from time to time.

 

Section 4.7 The Vice Presidents. If elected or appointed by the Board of Directors, the Vice President (or in the event there be more than one vice president, the vice presidents in the order designated at the time of their election, or in the absence of any designation, then in the order of their election) shall, in the absence of the President or in the event of his death or inability to act, perform all duties of the President, and when so acting, shall have all the powers of and be subject to all the restrictions upon the President. Any Vice President may sign, with the Secretary or an Assistant Secretary, certificates for shares of the corporation, and contracts or equipment leases entered into in the ordinary course of business; and shall perform such other duties as from time to time may be assigned to him by the President or by the Board of Directors.

 

 
7
 
 

 

Section 4.8 The Secretary. If elected or appointed by the Board of Directors, the Secretary shall: (a) keep the minutes of the proceedings of the shareholders and of the Board of Directors in one or more books provided for that purpose; (b) see that all notices are duly given in accordance with the provisions of these Bylaws or as required by law; (c) be custodian of the corporate records and of the seal of the corporation and see that the seal of the corporation is affixed to all documents the execution of which on behalf of the corporation under its seal is duly authorized; (d) keep a register of the post office address of each shareholder which shall be furnished to the Secretary by such shareholder; (e) sign with the President, or a Vice President, certificates for shares of the corporation, the issuance of which shall have been authorized by resolution of the Board of Directors; (f) have general charge of the stock transfer books of the corporation; (g) in general perform all duties incident to the office of Secretary and such other duties as from time to time may be assigned to him by the President or by the Board of Directors.

 

Section 4.9 The Treasurer. If elected or appointed by the Board of Directors, the Treasurer shall: (a) have charge and custody of and be responsible for all funds and securities of the corporation; (b) receive and give receipts for monies due and payable to the corporation from any source whatsoever, and deposit all such monies in the name of the corporation in such banks, trust companies or other depositories as shall be selected in accordance with the provisions of Article V of these Bylaws; and (c) in general perform all of the duties incident to the office of Treasurer and such other duties as from time to time may be assigned to him by the President or by the Board of Directors.

 

Section 4.10 Assistant Secretaries and Assistant Treasurers. The Assistant Secretaries, when authorized by the Board of Directors, may sign with the President or a Vice President certificates for shares of the corporation the issuance of which shall have been authorized by a resolution of the Board of Directors. The Assistant Secretaries and Assistant Treasurers, in general, shall perform such duties as shall be assigned to them by the Secretary or the Treasurer, respectively, or by the President or the Board of Directors.

 

Section 4.11 Bonds. If the Board of Directors by resolution shall so require, any officer or agent of the corporation shall give bond to the corporation in such amount and with such surety as the Board of Directors may deem sufficient, conditioned upon the faithful performance of their respective duties and offices.

 

Section 4.12 Salaries. The salaries of the officers shall be fixed from time to time by the Board of Directors and no officer shall be prevented from receiving such salary by reason of the fact that he is also a director of the corporation.

 

 
8
 
 

 

ARTICLE V

CONTRACTS, LOANS, CHECKS AND DEPOSITS

 

Section 5.1 Contracts. The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and deliver any instrument in the name of and on behalf of the corporation, and such authority may be general or confined to specific instances. The President or any Vice-President may enter into contracts or equipment leases entered into in the ordinary course of business.

 

Section 5.2 Loans. No loans shall be contracted on behalf of the corporation and no evidences of indebtedness shall be issued in its name unless authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances.

 

Section 5.3 Checks, Drafts, Etc. All checks, drafts or other orders for the payment of money, notes or other evidence of indebtedness issued in the name of the corporation shall be signed by such officer or officers, agent or agents of the corporation and in such manner as shall from time to time be determined by resolution of the Board of Directors.

 

Section 5.4 Deposits. All funds of the corporation not otherwise employed shall be deposited from time to time to the credit of the corporation in such banks, trust companies or other depositories as the Board of Directors may select.

 

ARTICLE VI

SHARES, CERTIFICATES FOR SHARES AND TRANSFER OF SHARES

 

Section 6.1 Regulations. The Board of Directors may make such rules and regulations as it may deem appropriate concerning the issuance, transfer and registration of certificates for shares of the corporation, including the appointment of transfer agents and registrars.

 

Section 6.2 Certificates for Shares. Certificates representing shares of the corporation shall comply with the statutes of the State of Wyoming and shall be signed by two executive officers of the corporation; provided that such signatures may be by facsimile if the certificate is counter signed by a transfer agent.

 

Section 6.3 Cancellation of Certificates. All certificates surrendered to the corporation for transfer shall be canceled and no new certificates shall be issued in lieu thereof until the former certificate for a like number of shares shall have been surrendered and canceled, except as herein provided with respect to lost, stolen or destroyed certificates.

 

Section 6.4 Lost, Stolen or Destroyed Certificates. Any shareholder claiming that his certificate for shares is lost, stolen or destroyed may make an affidavit or affirmation of that fact and lodge the same with the Secretary of the corporation, accompanied by a signed application for a new certificate. Thereupon, and upon the giving of a satisfactory bond of indemnity to the corporation not exceeding an amount double the value of the shares as represented by such certificate (the necessity for such bond and the amount required to be determined by the President and Treasurer of the corporation), a new certificate may be issued of the same tenor and representing the same number, class and series of shares as were represented by the certificate alleged to be lost, stolen or destroyed.

 

 
9
 
 

 

Section 6.5 Transfer of Shares. Subject to the terms of any shareholder agreement relating to the transfer of shares or other transfer restrictions contained in the Articles of Incorporation or authorized therein, shares of the corporation shall be transferable on the books of the corporation by the holder thereof in person or by his duly authorized attorney, upon the surrender and cancellation of a certificate or certificates for a like number of shares. Upon presentation and surrender of a certificate for shares properly endorsed and payment of all taxes therefor, the transferee shall be entitled to a new certificate or certificates in lieu thereof. As against the corporation, a transfer of shares can be made only on the books of the corporation and in the manner hereinabove provided, and the corporation shall be entitled to treat the holder of record of any shares as the owner thereof and shall not be bound to recognize any equitable or other claim to or interest in such shares on the part of any other person, whether or not it shall have express or other notice thereof, save as expressly provided by the statutes of the State of Wyoming.

 

Section 6.6 Shares Held for the Account of a Specified Person or Persons. The Board of Directors may adopt by resolution a procedure whereby a shareholder of the corporation may certify in writing to the corporation that all or a portion of the shares registered in the name of such shareholder are held for the account of a specified person or persons. The resolution shall set forth:

 

(a) The classification of shareholder who may certify;

 

(b) The purpose or purposes for which the certification may be made;

 

(c) The form of certification and information to be contained therein;

 

(d) If the certification is with respect to a record date or closing of the stock transfer books, the time after the record date or closing of the stock transfer books within which the certification must be received by the corporation; and

 

(e) Such other provisions with respect to the procedure as are deemed necessary or desirable.

 

Upon receipt by the corporation of a certification complying with the procedure, the persons specified in the certification shall be deemed, for the purpose or purposes set forth in the certification, to be the holders of record of the number of shares specified in place of the shareholder making the certification.

 

ARTICLE VII
TAXABLE YEAR

 

The taxable year of the corporation shall be determined by resolution of the Board of Directors.

 

 
10
 
 

 

ARTICLE VIII
DIVIDENDS

 

The Board of Directors may from time to time declare, and the corporation may pay, dividends on its outstanding shares in the manner and upon the terms and conditions provided by law and its Articles of Incorporation.

 

ARTICLE IX
CORPORATE SEAL

 

The Board of Directors may provide a corporate seal which shall be circular in form and shall have inscribed thereon the name of the corporation and the state of incorporation and the word “Seal.”

 

ARTICLE X

WAIVER OF NOTICE

 

Whenever any notice is required to be given under the provisions of these Bylaws or under the provisions of the Articles of Incorporation or under the provisions of the Wyoming Business Corporation Act, or otherwise, a waiver thereof in writing, signed by the person or persons entitled to such notice, whether before or after the event or other circumstance requiring such notice, shall be deemed equivalent to the giving of such notice.

 

ARTICLE XI

AMENDMENTS

 

These Bylaws may be altered, amended or repealed and new Bylaws may be adopted by a majority of the directors present at any meeting of the Board of Directors of the corporation at which a quorum is present.

 

ARTICLE XII
EXECUTIVE COMMITTEE

 

Section 12.1 Appointment. The Board of Directors by resolution adopted by a majority of the full Board, may designate two or more of its members to constitute an Executive Committee. The designation of such Committee and the delegation thereto of authority shall not operate to relieve the Board of Directors, or any member thereof, of any responsibility imposed by law.

 

Section 12.2 Authority. The Executive Committee, when the Board of Directors is not in session, shall have and may exercise all of the authority of the Board of Directors except to the extent, if any, that such authority shall be limited by the resolution appointing the Executive Committee and except also that the Executive Committee shall not have the authority of the Board of Directors in reference to amending the Articles of Incorporation, adopting a plan of merger or consolidation, recommending to the shareholders the sale, lease or other disposition of all or substantially all of the property and assets of the corporation otherwise than in the usual and regular course of its business, recommending to the shareholders a voluntary dissolution of the corporation or a revocation thereof, or amending the Bylaws of the corporation.

 

 
11
 
 

 

Section 12.3 Tenure and Qualifications. Each member of the Executive Committee shall hold office until the next regular annual meeting of the Board of Directors following his designation and until his successor is designated as a member of the Executive Committee and is elected and qualified.

 

Section 12.4 Meetings. Regular meetings of the Executive Committee may be held without notice at such time and places as the Executive Committee may fix from time to time by resolution. Special meetings of the Executive Committee may be called by any member thereof upon not less than one days notice stating the place, date and hour of the meeting, which notice may be written or oral, and if mailed, shall be deemed to be delivered when deposited in the United States mail addressed to the member of the Executive Committee at his business address. Any member of the Executive Committee may waive notice of any meeting and no notice of any meeting need be given to any member thereof who attends in person. The notice of a meeting of the Executive Committee need not state the business proposed to be transacted at the meeting.

 

Section 12.5 Quorum. A majority of the members of the Executive Committee shall constitute a quorum for the transaction of business at any meeting thereof, and action of the Executive Committee must be authorized by the affirmative vote of a majority of the members present at a meeting at which a quorum is present.

 

Section 12.6 Action by Executive Committee Without a Meeting. Any action required or permitted to be taken by the Executive Committee at a meeting may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the members entitled to vote with respect to the subject matter thereof.

 

Section 12.7 Vacancies. Any vacancy in the Executive Committee may be filled by a resolution adopted by a majority of the full Board of Directors.

 

Section 12.8 Resignations and Removal. Any member of the Executive Committee may be removed at any time with or without cause by resolution adopted by a majority of the full Board of Directors. Any member of the Executive Committee may resign from the Executive Committee at any time by giving written notice to the President or Secretary of the corporation, and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.

 

Section 12.9 Procedure. The Executive Committee shall elect a presiding officer from its members and may fix its own rules of procedure which shall not be inconsistent with these Bylaws. It shall keep regular minutes of its proceedings and report the same to the Board of Directors for its information at the meeting thereof held next after the proceedings shall have been taken.

 

 
12
 
 

 

ARTICLE XIII
EMERGENCY BYLAWS

 

The Emergency Bylaws provided in this Article XIII shall be operative during any emergency in the conduct of the business of the corporation resulting from an attack on the United States or any nuclear or atomic disaster, notwithstanding any different provision in the preceding articles of the Bylaws or in the Articles of Incorporation of the corporation or in the Wyoming Business Corporation Act. To the extent not inconsistent with the provisions of this article, the Bylaws provided in the preceding articles shall remain in effect during such emergency and upon its termination the Emergency Bylaws shall cease to be operative.

 

During any such emergency:

 

(a) A meeting of the Board of Directors may be called by any officer or director of the corporation. Notice of the time and place of the meeting shall be given by the person calling the meeting to such of the directors as it may be feasible to reach by any available means of communication. Such notice shall be given at such time in advance of the meeting as circumstances permit in the judgment of the person calling the meetings.

 

(b) At any such meeting of the Board of Directors, a quorum shall consist of the number of directors in attendance at such meeting.

 

(c) The Board of Directors, either before or during any such emergency, may, effective in the emergency, change the principal office or designate several alternative principal offices or regional offices, or authorize the officers so to do.

 

(d) The Board of Directors, either before or during any such emergency, may provide, and from time to time modify, lines of succession in the event that during such an emergency any or all officers or agents of the corporation shall for any reason be rendered incapable of discharging their duties.

 

(e) No officer, director or employee acting in accordance these Emergency Bylaws shall be liable except for willful misconduct.

 

(f) These Emergency Bylaws shall be subject to repeal or change by further action of the Board of Directors or by action of the shareholders, but no such repeal or change shall modify the provisions of the next preceding paragraph with regard to action taken prior to the time of such repeal or change. Any amendment of these Emergency Bylaws may make any further or different provision that may be practical and necessary for the circumstances of the emergency.

 

 
13

 

 

EXHIBIT 4.1

 

MEDX HOLDING INC.

SUBSCRIPTION AGREEMENT

 

NOTICE TO INVESTORS

 

THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES.

 

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES OR BLUE SKY LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND STATE SECURITIES OR BLUE SKY LAWS. ALTHOUGH AN OFFERING STATEMENT HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “SEC”), THAT OFFERING STATEMENT DOES NOT INCLUDE THE SAME INFORMATION THAT WOULD BE INCLUDED IN A REGISTRATION STATEMENT UNDER THE ACT. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC, ANY STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON THE MERITS OF THIS OFFERING OR THE ADEQUACY OR ACCURACY OF THE SUBSCRIPTION AGREEMENT OR ANY OTHER MATERIALS OR INFORMATION MADE AVAILABLE TO PROSPECTIVE INVESTOR IN CONNECTION WITH THIS OFFERING. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

 

THE SECURITIES CANNOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH THE SECURITIES ACT. IN ADDITION, THE SECURITIES CANNOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS. INVESTORS WHO ARE NOT “ACCREDITED INVESTORS” (AS THAT TERM IS DEFINED IN SECTION 501 OF REGULATION D PROMULGATED UNDER THE SECURITIES ACT) ARE SUBJECT TO LIMITATIONS ON THE AMOUNT THEY MAY INVEST, AS SET OUT IN SECTION 4(g). THE COMPANY IS RELYING ON THE REPRESENTATIONS AND WARRANTIES SET FORTH BY EACH INVESTOR IN THIS SUBSCRIPTION AGREEMENT AND THE OTHER INFORMATION PROVIDED BY INVESTOR IN CONNECTION WITH THIS OFFERING TO DETERMINE THE APPLICABILITY TO THIS OFFERING OF EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

 

PROSPECTIVE INVESTORS MAY NOT TREAT THE CONTENTS OF THE SUBSCRIPTION AGREEMENT, THE OFFERING CIRCULAR OR ANY OF THE OTHER MATERIALS PROVIDED BY THE COMPANY (COLLECTIVELY, THE “OFFERING MATERIALS”), OR ANY PRIOR OR SUBSEQUENT COMMUNICATIONS FROM THE COMPANY OR ANY OF ITS OFFICERS, EMPLOYEES OR AGENTS (INCLUDING “TESTING THE WATERS” MATERIALS) AS INVESTMENT, LEGAL OR TAX ADVICE. IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE COMPANY AND THE TERMS OF THIS OFFERING, INCLUDING THE MERITS AND THE RISKS INVOLVED. EACH PROSPECTIVE INVESTOR SHOULD CONSULT THE INVESTOR’S OWN COUNSEL, ACCOUNTANTS AND OTHER PROFESSIONAL ADVISORS AS TO INVESTMENT, LEGAL, TAX AND OTHER RELATED MATTERS CONCERNING THE INVESTOR’S PROPOSED INVESTMENT.

 

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

 
 
1
 
 

 

SUBSCRIPTION AGREEMENT

 

This subscription agreement (this “Subscription Agreement” or the “Agreement”) is entered into by and between MedX Holdings, Inc., a Wyoming corporation (hereinafter the “Company”) and the undersigned (hereinafter the “Investor”) as of the date set forth on the signature page hereto. Any term used but not defined herein shall have the meaning set forth in the Offering Circular (as defined below).

 

RECITALS

 

WHEREAS, the Company desires to offer shares of its common stock, par value $0.01 per share (the “Common Stock”) on a “best efforts” basis pursuant to Regulation A of Section 3(6) of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to a Tier 1 offering (the “Offering”), at a purchase price of $.005 per share (the “Per Share Purchase Price”), for total gross proceeds of up to $2,500,000 (the “Maximum Offering”); and

 

WHEREAS, the Investor desires to acquire that number of shares of Common Stock (the “Shares”) as set forth on the signature page hereto at the purchase price set forth herein; and

 

WHEREAS, the Offering will terminate on the first to occur of: (i) June 1, 2020, subject to extension for up to one hundred-eighty (180) days in the sole discretion of the Company; or (ii) the date on which the Maximum Offering is sold (in either case, the “Termination Date”).

 

NOW, THEREFORE, for and in consideration of the premises and the mutual covenants hereinafter set forth, the parties hereto do hereby agree as follows:

 

1. Subscription

 

(a) The Investor hereby irrevocably subscribes for and agrees to purchase the number of Shares set forth on the signature page hereto at the Per Share Purchase Price, upon the terms and conditions set forth herein. The aggregate purchase price for the Shares with respect to each Investor (the “Purchase Price”) is payable in the manner provided in Section 2(a) below.

 

(b) Investor understands that the Shares are being offered pursuant to the Form 1-A Regulation A Offering Circular dated ____________, 2019 and its exhibits as filed with and qualified by the Securities and Exchange Commission (the “SEC”) on ________________, 2019 (collectively, the “Offering Circular”). The Company will accept tenders of funds to purchase the Shares. The Company will close on investments on a “rolling basis,” pursuant to the terms of the Offering Circular. As a result, not all investors will receive their Shares on the same date.

 

(c) This subscription may be accepted or rejected in whole or in part, for any reason or for no reason, at any time prior to the Termination Date, by the Company at its sole and absolute discretion. In addition, the Company, at its sole and absolute discretion, may allocate to Investor only a portion of the number of the Shares that Investor has subscribed for hereunder. The Company will notify Investor whether this subscription is accepted (whether in whole or in part) or rejected. If Investor’s subscription is rejected, Investor’s payment (or portion thereof if partially rejected) will be returned to Investor without interest and all of Investor’s obligations hereunder shall terminate. In the event of rejection of this subscription in its entirety, or in the event the sale of the Shares (or any portion thereof) to an Investor is not consummated for any reason, this Subscription Agreement shall have no force or effect, except for Section 5 hereof, which shall remain in full force and effect.

 

(d) The terms of this Subscription Agreement shall be binding upon Investor and its permitted transferees, heirs, successors and assigns (collectively, the “Transferees”); provided, however, that for any such transfer to be deemed effective, the Transferee shall have executed and delivered to the Company in advance an instrument in form acceptable to the Company in its sole discretion, pursuant to which the proposed Transferee shall acknowledge and agree to be bound by the representations and warranties of Investor and the terms of this Subscription Agreement. No transfer of this Agreement may be made without the consent of the Company, which may be withheld in its sole and absolute discretion.

 
 
2
 
 

 

2. Payment and Purchase Procedure. The Purchase Price shall be paid simultaneously with Investor’s subscription. Investor shall deliver payment for the aggregate purchase price of the Shares by check, credit card, ACH deposit or by wire transfer to an account designated by the Company in Section 8 below. The Investor acknowledges that, in order to subscribe for Shares, he must fully comply with the purchase procedure requirements set forth in Section 8 below.

 

3. Representations and Warranties of the Company. The Company represents and warrants to Investor that the following representations and warranties are true and complete in all material respects as of the date of each Closing: (a) the Company is a corporation duly formed, validly existing and in good standing under the laws of the State of Wyoming. The Company has all requisite power and authority to own and operate its properties and assets, to execute and deliver this Subscription Agreement, the Shares and any other agreements or instruments required hereunder. The Company is duly qualified and is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not have a material adverse effect on the Company or its business; (b) The issuance, sale and delivery of the Shares in accordance with this Subscription Agreement have been duly authorized by all necessary corporate action on the part of the Company. The Shares, when issued, sold and delivered against payment therefor in accordance with the provisions of this Subscription Agreement, will be duly and validly issued, fully paid and non-assessable; (c) the acceptance by the Company of this Subscription Agreement and the consummation of the transactions contemplated hereby are within the Company’s powers and have been duly authorized by all necessary corporate action on the part of the Company. Upon the Company’s acceptance of this Subscription Agreement, this Subscription Agreement shall constitute a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies and (iii) with respect to provisions relating to indemnification and contribution, as limited by the Company’s certificate of incorporation, bylaws and the Wyoming Business Corporation Act in general.

 

4. Representations and Warranties of Investor. By subscribing to the Offering, Investor (and, if Investor is purchasing the Shares subscribed for hereby in a fiduciary capacity, the person or persons for whom Investor is so purchasing) represents and warrants, which representations and warranties are true and complete in all material respects, as of the date of each Closing:

 

(a) Requisite Power and Authority. Investor has all necessary power and authority under all applicable provisions of law to subscribe to the Offering, to execute and deliver this Subscription Agreement and to carry out the provisions thereof. All actions on Investor’s part required for the lawful subscription to the offering have been or will be effectively taken prior to the Closing. Upon subscribing to the Offering, this Subscription Agreement will be a valid and binding obligation of Investor, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights and (ii) as limited by general principles of equity that restrict the availability of equitable remedies.

 

(b) Company Offering Circular. Investor acknowledges the public availability of the Company’s Offering Circular which can be viewed on the SEC Edgar Database, under the CIK number 0001393901. This Offering Circular is made available in the Company’s qualified offering statement on SEC Form 1-A, as amended, and was qualified by the SEC on _______________. In the Company’s Offering Circular, it makes clear the terms and conditions of the offering of Shares and the risks associated therewith are described. Investor has had an opportunity to discuss the Company’s business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company’s operations and facilities. Investor has also had the opportunity to ask questions of and receive answers from the Company and its management regarding the terms and conditions of this investment. Investor acknowledges that except as set forth herein, no representations or warranties have been made to Investor, or to Investor’s advisors or representative, by the Company or others with respect to the business or prospects of the Company or its financial condition.

 
 
3
 
 

 

(c) Investment Experience; Investor Determination of Suitability. Investor has sufficient experience in financial and business matters to be capable of utilizing such information to evaluate the merits and risks of Investor’s investment in the Shares, and to make an informed decision relating thereto. Alternatively, the Investor has utilized the services of a purchaser representative and together they have sufficient experience in financial and business matters that they are capable of utilizing such information to evaluate the merits and risks of Investor’s investment in the Shares, and to make an informed decision relating thereto. Investor has evaluated the risks of an investment in the Shares, including those described in the section of the Offering Circular entitled “Risk Factors,” and has determined that the investment is suitable for Investor. Investor has adequate financial resources for an investment of this character. Investor could bear a complete loss of Investor’s investment in the Company.

 

(d) No Registration. Investor understands that the Shares are not being registered under the Securities Act on the ground that the issuance is exempt under Regulation A of Section 3(b) of the Securities Act, and that reliance on such exemption is predicated in part on the truth and accuracy of Investor's representations and warranties, and those of the other purchasers of the Shares, in the offering. Investor further understands that, at present, the Company is offering the Shares solely by members of its management. However, the Company reserves the right to engage the services of a broker/dealer who is registered with the Financial Industry Regulatory Authority (“FINRA”). Accordingly, until such FINRA registered broker/dealer has been engaged as a placement or selling agent, the Shares may not be “covered securities” under the National Securities Market Improvement Act of 1996, and the Company may be required to register or qualify the Shares under the securities laws of those states in which the Company intends to offer the Shares. In the event that Shares are so registered or qualified, the Company will notify the Investor and all prospective purchasers of the Shares as to those states in which the Company is permitted to offer and sell the Shares. In the event that the Company engages a FINRA registered broker/dealer as placement or selling agent, and FINRA approves the compensation of such broker/dealer, then the Shares will no longer be required to be registered under state securities laws on the basis that the issuance thereof is exempt as an offer and sale not involving a registrable public offering in such state, as the Shares will be “covered securities” under the National Securities Market Improvement Act of 1996. The Investor covenants not to sell, transfer or otherwise dispose of any Shares unless such Shares have been registered under the applicable state securities laws in which the Shares are sold, or unless exemptions from such registration requirements are otherwise available.

 

(e) Illiquidity and Continued Economic Risk. Investor acknowledges and agrees that there is no ready public market for the Shares and that there is no guarantee that a market for their resale will ever exist. The Company has no obligation to list any of the Shares on any market or take any steps (including registration under the Securities Act or the Securities Exchange Act of 1934, as amended) with respect to facilitating trading or resale of the Shares. Investor must bear the economic risk of this investment indefinitely and Investor acknowledges that Investor is able to bear the economic risk of losing Investor’s entire investment in the Shares.

 

(f) Accredited Investor Status or Investment Limits. Investor represents that either:

 

 

(i)

that Investor is an “accredited investor” within the meaning of Rule 501 of Regulation D under the Shares Act; or

 

 

(ii)

that the Purchase Price, together with any other amounts previously used to purchase Shares in this offering, does not exceed Ten Percent (10%) of the greater of Investor’s annual income or net worth (or in the case where Investor is a non-natural person, their revenue or net assets for such Investor's most recently completed fiscal year end).

 

Investor represents that to the extent it has any questions with respect to its status as an accredited investor, or the application of the investment limits, it has sought professional advice.

 

(g) Stockholder Information. Within five (5) days after receipt of a request from the Company, Investor hereby agrees to provide such information with respect to its status as a stockholder (or potential stockholder) and to execute and deliver such documents as may reasonably be necessary to comply with any and all laws and regulations to which the Company is or may become subject, including, without limitation, the need to determine the accredited investor status of the Company’s stockholders. Investor further agrees that in the event it transfers any Shares, it will require the transferee of such Shares to agree to provide such information to the Company as a condition of such transfer.

 
 
4
 
 

 

(h) Valuation; Arbitrary Determination of Per Share Purchase Price by the Company. Investor acknowledges that the Per Share Purchase Price of the Shares to be sold in this offering was set by the Company on the basis of the Company’s internal valuation and no warranties are made as to value. Investor further acknowledges that future offerings of securities of the Company may be made at lower valuations, with the result that Investor’s investment will bear a lower valuation.

 

(i) Domicile. Investor maintains Investor’s domicile (and is not a transient or temporary resident) at the address provided with Investors subscription.

 

(j) Foreign Investors. If Investor is not a United States person (as defined by Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended), Investor hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Shares or any use of this Subscription Agreement, including (i) the legal requirements within its jurisdiction for the purchase of the Shares, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the Shares. Investor’s subscription and payment for and continued beneficial ownership of the Shares will not violate any applicable securities or other laws of Investor’s jurisdiction.

 

(k) Fiduciary Capacity. If Investor is purchasing the Shares in a fiduciary capacity for another person or entity, including without limitation a corporation, partnership, trust or any other entity, the Investor has been duly authorized and empowered to execute this Agreement and all other subscription documents. Upon request of the Company, Investor will provide true, complete and current copies of all relevant documents creating the Investor, authorizing its investment in the Company and/or evidencing the satisfaction of the foregoing.

 

5. Indemnity. The representations, warranties and covenants made by Investor herein shall survive the closing of this Subscription Agreement. Investor agrees to indemnify and hold harmless the Company and its respective officers, directors and affiliates, and each other person, if any, who controls the Company within the meaning of Section 15 of the Securities Act against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all reasonable attorneys’ fees, including attorneys’ fees on appeal) and expenses reasonably incurred in investigating, preparing or defending against any false representation or warranty or breach of failure by Investor to comply with any covenant or agreement made by Investor herein or in any other document furnished by Investor to any of the foregoing in connection with this transaction.

 

6. Governing Law; Jurisdiction; Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of the Offering Circular, including, without limitation, this Subscription Agreement, shall be governed by and construed and enforced in accordance with the internal laws of the State of Wyoming, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Subscription Agreement and any documents included within the Offering Circular (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in Broward County, Florida. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Broward County, Florida for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the documents included within the Offering Circular), and hereby irrevocably waives, and agrees not to assert in any action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Subscription Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party hereto shall commence an action or proceeding to enforce any provisions of the documents included within the Offering Circular, then the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 
 
5
 
 

 

7. Notices. Notice, requests, demands and other communications relating to this Subscription Agreement and the transactions contemplated herein shall be in writing and shall be deemed to have been duly given if and when (a) delivered personally, on the date of such delivery; or (b) mailed by registered or certified mail, postage prepaid, return receipt requested, in the third day after the posting thereof; or (c) emailed on the date of such delivery to the address of the respective parties as follows, if to the Company, to MedX Holdings Inc., 1621 Central Ave., Cheyenne, WY 82001, Attention: Mark Miller, Chief Executive Officer. If to Investor, at Investor’s address supplied in connection with this subscription, or to such other address as may be specified by written notice from time to time by the party entitled to receive such notice. Any notices, requests, demands or other communications by email shall be confirmed by letter given in accordance with (a) or (b) above.

 

8. Purchase Procedure. The Investor acknowledges that, in order to subscribe for Shares, he must, and he does hereby, deliver to the Company: (a) a fully completed and executed counterpart of the Signature Page attached to this Subscription Agreement; and (b) payment for the aggregate Purchase Price in the amount set forth on the Signature Page attached to this Agreement. Payment may be made by either check, wire, credit card or ACH deposits.

 

Please send checks to the Company.

 

MedX Holdings Inc.

Attention: Mark Miller, Chief Executive Officer

1621 Central Ave.,

Cheyenne, WY 82001

 

Wire instructions:

 

Name and Address of Bank:

ABA #

Account#

 

For the benefit of: MedX Holdings Regulation A

 

9. Miscellaneous. All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural, as the identity of the person or persons or entity or entities may require. Other than as set forth herein, this Subscription Agreement is not transferable or assignable by Investor. The representations, warranties and agreements contained herein shall be deemed to be made by and be binding upon Investor and its heirs, executors, administrators and successors and shall inure to the benefit of the Company and its successors and assigns. None of the provisions of this Subscription Agreement may be waived, changed or terminated orally or otherwise, except as specifically set forth herein or except by a writing signed by the Company and Investor. In the event any part of this Subscription Agreement is found to be void or unenforceable, the remaining provisions are intended to be separable and binding with the same effect as if the void or unenforceable part were never the subject of agreement. The invalidity, illegality or unenforceability of one or more of the provisions of this Subscription Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the remainder of this Subscription Agreement in such jurisdiction or the validity, legality or enforceability of this Subscription Agreement, including any such provision, in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law. This Subscription Agreement supersedes all prior discussions and agreements between the parties, if any, with respect to the subject matter hereof and contains the sole and entire agreement between the parties hereto with respect to the subject matter hereof. The terms and provisions of this Subscription Agreement are intended solely for the benefit of each party hereto and their respective successors and assigns, and it is not the intention of the parties to confer, and no provision hereof shall confer, third-party beneficiary rights upon any other person. The headings used in this Subscription Agreement have been inserted for convenience of reference only and do not define or limit the provisions hereof. In the event that either party hereto shall commence any suit, action or other proceeding to interpret this Subscription Agreement, or determine to enforce any right or obligation created hereby, then such party, if it prevails in such action, shall recover its reasonable costs and expenses incurred in connection therewith, including, but not limited to, reasonable attorney’s fees and expenses and costs of appeal, if any. All notices and communications to be given or otherwise made to Investor shall be deemed to be sufficient if sent by e-mail to such address provided by Investor on the signature page of this Subscription Agreement. Unless otherwise specified in this Subscription Agreement, Investor shall send all notices or other communications required to be given hereunder to the Company by email to mark@medxholdings.co followed by a copy via FedEx or other national overnight courier service. Any such notice or communication shall be deemed to have been delivered and received on the first business day following that on which the e-mail has been sent (assuming that there is no error in delivery). As used in this Section 9, the term “business day” shall mean any day other than a day on which banking institutions in the State of California are legally closed for business. This Subscription Agreement may be executed in one or more counterparts. No failure or delay by any party in exercising any right, power or privilege under this Subscription Agreement shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.

 
 
6
 
 

 

10. Consent to Electronic Delivery of Notices, Disclosures and Forms. Investor understands that, to the fullest extent permitted by law, any notices, disclosures, forms, privacy statements, reports or other communications (collectively, “Communications”) regarding the Company, the Investor’s investment in the Company and the shares of Common Stock (including annual and other updates and tax documents) may be delivered by electronic means, such as by e-mail. Investor hereby consents to electronic delivery as described in the preceding sentence. In so consenting, Investor acknowledges that e-mail messages are not secure and may contain computer viruses or other defects, may not be accurately replicated on other systems or may be intercepted, deleted or interfered with, with or without the knowledge of the sender or the intended recipient. The Investor also acknowledges that an e-mail from the Company may be accessed by recipients other than the Investor and may be interfered with, may contain computer viruses or other defects and may not be successfully replicated on other systems. Neither the Company, nor any of its respective officers, directors and affiliates, and each other person, if any, who controls the Company within the meaning of Section 15 of the Securities Act (collectively, the “Company Parties”), gives any warranties in relation to these matters. Investor further understands and agrees to each of the following: (a) other than with respect to tax documents in the case of an election to receive paper versions, none of the Company Parties will be under any obligation to provide Investor with paper versions of any Communications; (b) electronic Communications may be provided to Investor via e-mail or a website of a Company Party upon written notice of such website’s internet address to such Investor. In order to view and retain the Communications, the Investor’s computer hardware and software must, at a minimum, be capable of accessing the Internet, with connectivity to an internet service provider or any other capable communications medium, and with software capable of viewing and printing a portable document format (“PDF”) file created by Adobe Acrobat. Further, the Investor must have a personal e-mail address capable of sending and receiving e-mail messages to and from the Company Parties. To print the documents, the Investor will need access to a printer compatible with his or her hardware and the required software; (c) if these software or hardware requirements change in the future, a Company Party will notify the Investor through written notification. To facilitate these services, the Investor must provide the Company with his or her current e-mail address and update that information as necessary. Unless otherwise required by law, the Investor will be deemed to have received any electronic Communications that are sent to the most current e-mail address that the Investor has provided to the Company in writing; (d) none of the Company Parties will assume liability for non-receipt of notification of the availability of electronic Communications in the event the Investor’s e-mail address on file is invalid; the Investor’s e-mail or Internet service provider filters the notification as “spam” or “junk mail”; there is a malfunction in the Investor’s computer, browser, internet service or software; or for other reasons beyond the control of the Company Parties; and (e) solely with respect to the provision of tax documents by a Company Party, the Investor agrees to each of the following: (i) if the Investor does not consent to receive tax documents electronically, a paper copy will be provided, and (ii) the Investor’s consent to receive tax documents electronically continues for every tax year of the Company until the Investor withdraws its consent by notifying the Company in writing.

 

[THIS SPACE IS INTENTIONALLY LEFT BLANK]

 

[SIGNATURE PAGE TO FOLLOW]

 
 
7
 
 

 

INVESTOR CERTIFIES THAT HE HAS READ THIS ENTIRE SUBSCRIPTION AGREEMENT AND THAT EVERY STATEMENT MADE BY THE INVESTOR HEREIN IS TRUE AND COMPLETE.

 

THE COMPANY MAY NOT BE OFFERING THE SECURITIES IN EVERY STATE. THE OFFERING MATERIALS DO NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY STATE OR JURISDICTION IN WHICH THE SECURITIES ARE NOT BEING OFFERED. THE INFORMATION PRESENTED IN THE OFFERING MATERIALS WAS PREPARED BY THE COMPANY SOLELY FOR THE USE BY PROSPECTIVE INVESTORS IN CONNECTION WITH THIS OFFERING. NO REPRESENTATIONS OR WARRANTIES ARE MADE AS TO THE ACCURACY OR COMPLETENESS OF THE INFORMATION CONTAINED IN ANY OFFERING MATERIALS, AND NOTHING CONTAINED IN THE OFFERING MATERIALS IS OR SHOULD BE RELIED UPON AS A PROMISE OR REPRESENTATION AS TO THE FUTURE PERFORMANCE OF THE COMPANY.

 

THE COMPANY RESERVES THE RIGHT IN ITS SOLE DISCRETION AND FOR ANY REASON WHATSOEVER TO MODIFY, AMEND AND/OR WITHDRAW ALL OR A PORTION OF THE OFFERING AND/OR ACCEPT OR REJECT, IN WHOLE OR IN PART, FOR ANY REASON OR FOR NO REASON, ANY PROSPECTIVE INVESTMENT IN THE SECURITIES OR TO ALLOT TO ANY PROSPECTIVE INVESTOR LESS THAN THE DOLLAR AMOUNT OF SECURITIES SUCH INVESTOR DESIRES TO PURCHASE. EXCEPT AS OTHERWISE INDICATED, THE OFFERING MATERIALS SPEAK AS OF THEIR DATE. NEITHER THE DELIVERY NOR THE PURCHASE OF THE SECURITIES SHALL, UNDER ANY CIRCUMSTANCES, CREATE ANY IMPLICATION THAT THERE HAS BEEN NO CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THAT DATE.

 

IN WITNESS WHEREOF, this Subscription Agreement is executed as of the ______ day of _________, 2019.

 

Number of Shares Subscribed For:

 

 

Total Purchase Price:

$

 

 

Signature of Investor:

 

 

Name of Investor:

 

 

Address of Investor:

 

 

Electronic Mail Address:

 

 

Investor’s SS# or Tax ID#:

 

ACCEPTED BY: MEDX HOLDINGS INC.

 

Signature of Authorized Signatory: __________________________________

 

Name of Authorized Signatory: Mark Miller, President and CEO

 

Date of Acceptance: _________________, 2019.

 

[SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT]

 

 
8

 

EXHIBIT 12.1

 

JONATHAN D. LEINWAND, P.A.

18851 NE 29th Ave.

 Suite 1011

Aventura, FL 33180

Tel: (954) 903-7856

Fax: (954) 252-4265

  

E-mail: jonathan@jdlpa.com

 

September 19, 2019

 

MedX Holdings, Inc

1621 Central Avenue

Cheyenne, WY 82001

 

Gentlemen:

 

We have acted, at your request, as special counsel to MedX Holdings Inc., a Wyoming corporation, (“MedX”) for the purpose of rendering an opinion as to the legality of 250,000,000 shares of MedX common stock, par value $0.001 per share to be offered and distributed by MedX (the “Shares”), pursuant to an Offering Statement to be filed under Regulation A of the Securities Act of 1933, as amended, by MedX with the U.S. Securities and Exchange Commission (the "SEC") on Form 1-A, for the purpose of registering the offer and sale of the Shares (“Offering Statement”).

 

For the purpose of rendering my opinion herein, we have reviewed statutes of the State of Wyoming, to the extent WE deem relevant to the matter opined upon herein, certified or purported true copies of the Articles of Incorporation of MedX and all amendments thereto, the By-Laws of MedX, selected proceedings of the board of directors of MedX authorizing the issuance of the Shares, certificates of officers of MedX and of public officials, and such other documents of MedX and of public officials as We have deemed necessary and relevant to the matter opined upon herein. We have assumed, with respect to persons other than directors and officers of MedX, the due and proper election or appointment of all persons signing and purporting to sign the documents in their respective capacities, as stated therein, the genuineness of all signatures, the conformity to authentic original documents of the copies of all such documents submitted to me as certified, conformed and photocopied, including the quoted, extracted, excerpted and reprocessed text of such documents.

 

On the basis of such examination, we are of the opinion that:

 

1. The Shares have been duly authorized by all necessary corporate action of the Company as the Board has been authorized by the shareholders to increase the authorized as need to accommodate the offering underlying.

 

2. When issued and sold by the Company against payment therefor pursuant to the terms of the Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable.

 

This opinion is strictly limited to matters of Wyoming corporation law.

 
 
1
 
 

 

We hereby consent to the use of our name in the Offering Statement and we also consent to the filing of this opinion as an exhibit thereto. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933 or the rules and regulations of the Commission thereunder.

 

  Very Truly Yours,

JONATHAN D. LEINWAND, P.A.

        
By: /s/ Jonathan Leinwand
    Jonathan Leinwand, Esq.  

 

 

 

 

 

 

 

 

 

JONATHAN D. LEINWAND, P.A.

18851 NE 29th Ave. • Suite 1011 • Aventura, FL 33180 • Tel: (954) 903-7856 • Fax: (954) 252-4265

www.jdlpa.com

 

 
2